Hepatitis B infection is caused by the Hepatitis B Virus. Hepatitis B virus is spread by contact with contaminated blood and body fluids. Chronic infection with Hepatitis B virus results in damage to the liver, cirrhosis and/or liver cancer. The body’s immune system is responsible for the liver tissue damage because it destroys the liver cells containing the virus. Consumption of alcohol during infection with Hepatitis B virus is discouraged because it can increase the damage to the liver. Hepatitis B virus is prevented by cautious and safe handling of blood and body fluids, vaccination, and refraining from behavior known to be associated with acquisition of the virus. Serology testing to detect hepatitis B surface antigen (HBsAg) is the standard for diagnosing the disease.
In hepatitis B virus infection, surface antigen is detectable 2 – 5 weeks before onset of symptoms, rises in titer, and peaks at about the time of onset of clinical illness. Generally it persists for 1 – 5 months, declining in titer and disappearing with resolution of clinical symptoms. HBsAg is a first-line test for the diagnosis of acute or chronic hepatitis B. If positive, no other test is needed. HBsAg is an indicator for active infection. It is a marker used for detecting initial infection, monitoring the course of the infection, and progression to chronic disease. It is also used in the screening of donor blood.
Note: In rare cases HBsAg might be negative (when tested early). If clinical suspicion is high, HBcAb (IgM) test is then indicated.
Negative (Non-reactive)
Enzyme immunoassay, Chemiluminescence immunoassay.
HBsAg is definitive for diagnosing infection with Hepatitis B Virus. Other tests useful in monitoring HBV Infection: Total Anti-HBc, HBeAg, HBV DNA, Liver Function Tests, Lactate Dehydrogenase, Liver Biopsy.
1-3 days.
| 87340 | $10.33 |
| 87341 | $10.33 |
| 87467 | $0 |
| A15 | Respiratory tuberculosis |
| A15.0 | Tuberculosis of lung |
| A17 | Tuberculosis of nervous system |
| A18 | Tuberculosis of other organs |
| A18.11 | Tuberculosis of kidney and ureter |
| A19 | Miliary tuberculosis |
| A19.0 | Acute miliary tuberculosis of a single specified site |
| A19.1 | Acute miliary tuberculosis of multiple sites |
| A19.2 | Acute miliary tuberculosis, unspecified |
| A19.9 | Miliary tuberculosis, unspecified |
| A31 | Infection due to other mycobacteria |
| B02 | Zoster [herpes zoster] |
| B02.23 | Postherpetic polyneuropathy |
| B15 | Acute hepatitis A |
| B16 | Acute hepatitis B |
| B16.9 | Acute hepatitis B without delta-agent and without hepatic coma |
| B17 | Other acute viral hepatitis |
| B17.0 | Acute delta-(super) infection of hepatitis B carrier |
| B17.8 | Other specified acute viral hepatitis |
| B18 | Chronic viral hepatitis |
| B18.0 | Chronic viral hepatitis B with delta-agent |
| B18.1 | Chronic viral hepatitis B without delta-agent |
| B18.2 | Chronic viral hepatitis C |
| B18.8 | Other chronic viral hepatitis |
| B18.9 | Chronic viral hepatitis, unspecified |
| B19 | Unspecified viral hepatitis |
| B19.0 | Unspecified viral hepatitis with hepatic coma |
| B19.1 | Unspecified viral hepatitis B |
| B19.10 | Unspecified viral hepatitis B without hepatic coma |
| B19.11 | Unspecified viral hepatitis B with hepatic coma |
| B19.9 | Unspecified viral hepatitis without hepatic coma |
| B90 | Sequelae of tuberculosis |
| C22 | Malignant neoplasm of liver and intrahepatic bile ducts |
| C22.0 | Liver cell carcinoma |
| C22.1 | Intrahepatic bile duct carcinoma |
| C22.8 | Malignant neoplasm of liver, primary, unspecified as to type |
| C22.9 | Malignant neoplasm of liver, not specified as primary or secondary |
| C24 | Malignant neoplasm of other and unspecified parts of biliary tract |
| C24.0 | Malignant neoplasm of extrahepatic bile duct |
| C77 | Secondary and unspecified malignant neoplasm of lymph nodes |
| C77.8 | Secondary and unspecified malignant neoplasm of lymph nodes of multiple regions |
| C77.9 | Secondary and unspecified malignant neoplasm of lymph node, unspecified |
| C82 | Follicular lymphoma |
| C82.89 | Other types of follicular lymphoma, extranodal and solid organ sites |
| C82.90 | Follicular lymphoma, unspecified, unspecified site |
| C82.99 | Follicular lymphoma, unspecified, extranodal and solid organ sites |
| C83 | Non-follicular lymphoma |
| C83.1 | Mantle cell lymphoma |
| C83.10 | Mantle cell lymphoma, unspecified site |
| C83.11 | Mantle cell lymphoma, lymph nodes of head, face, and neck |
| C83.12 | Mantle cell lymphoma, intrathoracic lymph nodes |
| C83.13 | Mantle cell lymphoma, intra-abdominal lymph nodes |
| C83.14 | Mantle cell lymphoma, lymph nodes of axilla and upper limb |
| C83.15 | Mantle cell lymphoma, lymph nodes of inguinal region and lower limb |
| C83.16 | Mantle cell lymphoma, intrapelvic lymph nodes |
| C83.17 | Mantle cell lymphoma, spleen |
| C83.18 | Mantle cell lymphoma, lymph nodes of multiple sites |
| C83.19 | Mantle cell lymphoma, extranodal and solid organ sites |
| C83.3 | Diffuse large B-cell lymphoma |
| C83.30 | Diffuse large B-cell lymphoma, unspecified site |
| C85 | Other specified and unspecified types of non-Hodgkin lymphoma |
| C85.8 | Other specified types of non-Hodgkin lymphoma |
| C85.80 | Other specified types of non-Hodgkin lymphoma, unspecified site |
| C85.86 | Other specified types of non-Hodgkin lymphoma, intrapelvic lymph nodes |
| C85.89 | Other specified types of non-Hodgkin lymphoma, extranodal and solid organ sites |
| C85.9 | Non-Hodgkin lymphoma, unspecified |
| C85.90 | Non-Hodgkin lymphoma, unspecified, unspecified site |
| C85.91 | Non-Hodgkin lymphoma, unspecified, lymph nodes of head, face, and neck |
| C85.92 | Non-Hodgkin lymphoma, unspecified, intrathoracic lymph nodes |
| C85.93 | Non-Hodgkin lymphoma, unspecified, intra-abdominal lymph nodes |
| C88 | Malignant immunoproliferative diseases and certain other B-cell lymphomas |
| D13 | Benign neoplasm of other and ill-defined parts of digestive system |
| D13.4 | Benign neoplasm of liver |
| D13.5 | Benign neoplasm of extrahepatic bile ducts |
| D69 | Purpura and other hemorrhagic conditions |
| D69.3 | Immune thrombocytopenic purpura |
| D69.4 | Other primary thrombocytopenia |
| D69.6 | Thrombocytopenia, unspecified |
| D69.8 | Other specified hemorrhagic conditions |
| D89 | Other disorders involving the immune mechanism, not elsewhere classified |
| D89.1 | Cryoglobulinemia |
| E10.41 | Type 1 diabetes mellitus with diabetic mononeuropathy |
| E71.522 | Adrenomyeloneuropathy |
| F11 | Opioid related disorders |
| F11.1 | Opioid abuse |
| F11.10 | Opioid abuse, uncomplicated |
| F11.12 | Opioid abuse with intoxication |
| F11.2 | Opioid dependence |
| F11.20 | Opioid dependence, uncomplicated |
| F11.21 | Opioid dependence, in remission |
| F11.9 | Opioid use, unspecified |
| F11.90 | Opioid use, unspecified, uncomplicated |
| F11.92 | Opioid use, unspecified with intoxication |
| F12 | Cannabis related disorders |
| F12.1 | Cannabis abuse |
| F13 | Sedative, hypnotic, or anxiolytic related disorders |
| F13.1 | Sedative, hypnotic or anxiolytic-related abuse |
| F13.10 | Sedative, hypnotic or anxiolytic abuse, uncomplicated |
| F14 | Cocaine related disorders |
| F14.1 | Cocaine abuse |
| F15 | Other stimulant related disorders |
| F15.1 | Other stimulant abuse |
| F15.10 | Other stimulant abuse, uncomplicated |
| F16 | Hallucinogen related disorders |
| F16.1 | Hallucinogen abuse |
| F17.2 | Nicotine dependence |
| F18 | Inhalant related disorders |
| F18.1 | Inhalant abuse |
| F18.10 | Inhalant abuse, uncomplicated |
| F19 | Other psychoactive substance related disorders |
| F19.1 | Other psychoactive substance abuse |
| F19.10 | Other psychoactive substance abuse, uncomplicated |
| F19.11 | Other psychoactive substance abuse, in remission |
| F19.12 | Other psychoactive substance abuse with intoxication |
| F19.2 | Other psychoactive substance dependence |
| F19.20 | Other psychoactive substance dependence, uncomplicated |
| F19.9 | Other psychoactive substance use, unspecified |
| F55 | Abuse of non-psychoactive substances |
| G58 | Other mononeuropathies |
| G58.9 | Mononeuropathy, unspecified |
| G60 | Hereditary and idiopathic neuropathy |
| G60.0 | Hereditary motor and sensory neuropathy |
| G60.3 | Idiopathic progressive neuropathy |
| G60.8 | Other hereditary and idiopathic neuropathies |
| G61 | Inflammatory polyneuropathy |
| G61.1 | Serum neuropathy |
| G62 | Other and unspecified polyneuropathies |
| G62.9 | Polyneuropathy, unspecified |
| G63 | Polyneuropathy in diseases classified elsewhere |
| G90.0 | Idiopathic peripheral autonomic neuropathy |
| G99 | Other disorders of nervous system in diseases classified elsewhere |
| G99.0 | Autonomic neuropathy in diseases classified elsewhere |
| I12 | Hypertensive chronic kidney disease |
| I12.0 | Hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease |
| I13 | Hypertensive heart and chronic kidney disease |
| I77 | Other disorders of arteries and arterioles |
| I77.6 | Arteritis, unspecified |
| K65 | Peritonitis |
| K65.1 | Peritoneal abscess |
| K70 | Alcoholic liver disease |
| K70.0 | Alcoholic fatty liver |
| K70.1 | Alcoholic hepatitis |
| K70.10 | Alcoholic hepatitis without ascites |
| K70.11 | Alcoholic hepatitis with ascites |
| K70.9 | Alcoholic liver disease, unspecified |
| K71 | Toxic liver disease |
| K71.3 | Toxic liver disease with chronic persistent hepatitis |
| K71.9 | Toxic liver disease, unspecified |
| K72 | Hepatic failure, not elsewhere classified |
| K72.0 | Acute and subacute hepatic failure |
| K72.00 | Acute and subacute hepatic failure without coma |
| K72.01 | Acute and subacute hepatic failure with coma |
| K72.11 | Chronic hepatic failure with coma |
| K72.90 | Hepatic failure, unspecified without coma |
| K72.91 | Hepatic failure, unspecified with coma |
| K73 | Chronic hepatitis, not elsewhere classified |
| K73.9 | Chronic hepatitis, unspecified |
| K74 | Fibrosis and cirrhosis of liver |
| K74.0 | Hepatic fibrosis |
| K74.6 | Other and unspecified cirrhosis of liver |
| K74.60 | Unspecified cirrhosis of liver |
| K74.69 | Other cirrhosis of liver |
| K75 | Other inflammatory liver diseases |
| K75.0 | Abscess of liver |
| K75.4 | Autoimmune hepatitis |
| K75.81 | Nonalcoholic steatohepatitis (NASH) |
| K76 | Other diseases of liver |
| K76.0 | Fatty (change of) liver, not elsewhere classified |
| K76.1 | Chronic passive congestion of liver |
| K76.2 | Central hemorrhagic necrosis of liver |
| K76.3 | Infarction of liver |
| K76.8 | Other specified diseases of liver |
| K76.89 | Other specified diseases of liver |
| K76.9 | Liver disease, unspecified |
| K77 | Liver disorders in diseases classified elsewhere |
| L93 | Lupus erythematosus |
| L95 | Vasculitis limited to skin, not elsewhere classified |
| M05.2 | Rheumatoid vasculitis with rheumatoid arthritis |
| M05.5 | Rheumatoid polyneuropathy with rheumatoid arthritis |
| M13.0 | Polyarthritis, unspecified |
| M25.48 | Effusion, other site |
| M25.5 | Pain in joint |
| M30 | Polyarteritis nodosa and related conditions |
| M30.0 | Polyarteritis nodosa |
| M30.1 | Polyarteritis with lung involvement [Churg-Strauss] |
| M30.8 | Other conditions related to polyarteritis nodosa |
| M31 | Other necrotizing vasculopathies |
| M31.1 | Thrombotic microangiopathy |
| M31.3 | Wegener's granulomatosis |
| M31.30 | Wegener's granulomatosis without renal involvement |
| M31.31 | Wegener's granulomatosis with renal involvement |
| M31.4 | Aortic arch syndrome [Takayasu] |
| M32 | Systemic lupus erythematosus (SLE) |
| M32.0 | Drug-induced systemic lupus erythematosus |
| N00 | Acute nephritic syndrome |
| N00.3 | Acute nephritic syndrome with diffuse mesangial proliferative glomerulonephritis |
| N00.8 | Acute nephritic syndrome with other morphologic changes |
| N00.9 | Acute nephritic syndrome with unspecified morphologic changes |
| N02 | Recurrent and persistent hematuria |
| N02.8 | Recurrent and persistent hematuria with other morphologic changes |
| N03 | Chronic nephritic syndrome |
| N03.0 | Chronic nephritic syndrome with minor glomerular abnormality |
| N03.2 | Chronic nephritic syndrome with diffuse membranous glomerulonephritis |
| N03.5 | Chronic nephritic syndrome with diffuse mesangiocapillary glomerulonephritis |
| N03.7 | Chronic nephritic syndrome with diffuse crescentic glomerulonephritis |
| N03.9 | Chronic nephritic syndrome with unspecified morphologic changes |
| N04 | Nephrotic syndrome |
| N04.8 | Nephrotic syndrome with other morphologic changes |
| N04.9 | Nephrotic syndrome with unspecified morphologic changes |
| N05 | Unspecified nephritic syndrome |
| N05.2 | Unspecified nephritic syndrome with diffuse membranous glomerulonephritis |
| N05.5 | Unspecified nephritic syndrome with diffuse mesangiocapillary glomerulonephritis |
| N06 | Isolated proteinuria with specified morphological lesion |
| N08 | Glomerular disorders in diseases classified elsewhere |
| N13 | Obstructive and reflux uropathy |
| N18 | Chronic kidney disease (CKD) |
| N18.6 | End stage renal disease |
| N18.9 | Chronic kidney disease, unspecified |
| N23 | Unspecified renal colic |
| N26 | Unspecified contracted kidney |
| N26.9 | Renal sclerosis, unspecified |
| N98.3 | Complications of attempted introduction of embryo in embryo transfer |
| O09 | Supervision of high risk pregnancy |
| O09.3 | Supervision of pregnancy with insufficient antenatal care |
| O12 | Gestational [pregnancy-induced] edema and proteinuria without hypertension |
| O26 | Maternal care for other conditions predominantly related to pregnancy |
| O28 | Abnormal findings on antenatal screening of mother |
| O28.9 | Unspecified abnormal findings on antenatal screening of mother |
| O36.01 | Maternal care for anti-D [Rh] antibodies |
| O99.01 | Anemia complicating pregnancy |
| O99.280 | Endocrine, nutritional and metabolic diseases complicating pregnancy, unspecified trimester |
| P58 | Neonatal jaundice due to other excessive hemolysis |
| P59 | Neonatal jaundice from other and unspecified causes |
| P59.0 | Neonatal jaundice associated with preterm delivery |
| P59.9 | Neonatal jaundice, unspecified |
| R05 | Cough |
| R16 | Hepatomegaly and splenomegaly, not elsewhere classified |
| R17 | Unspecified jaundice |
| R18 | Ascites |
| R18.8 | Other ascites |
| R19 | Other symptoms and signs involving the digestive system and abdomen |
| R19.0 | Intra-abdominal and pelvic swelling, mass and lump |
| R43.0 | Anosmia |
| R74.0 | Nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [LDH] |
| R77 | Other abnormalities of plasma proteins |
| R78 | Findings of drugs and other substances, not normally found in blood |
| R78.1 | Finding of opiate drug in blood |
| R78.2 | Finding of cocaine in blood |
| R78.4 | Finding of other drugs of addictive potential in blood |
| R78.5 | Finding of other psychotropic drug in blood |
| R80 | Proteinuria |
| R94 | Abnormal results of function studies |
| R94.4 | Abnormal results of kidney function studies |
| R94.5 | Abnormal results of liver function studies |
| T39 | Poisoning by, adverse effect of and underdosing of nonopioid analgesics, antipyretics and antirheumatics |
| T39.013 | Poisoning by aspirin, assault |
| T39.094S | Poisoning by salicylates, undetermined, sequela |
| T39.1 | Poisoning by, adverse effect of and underdosing of 4-Aminophenol derivatives |
| T39.1X1 | Poisoning by 4-Aminophenol derivatives, accidental (unintentional) |
| T39.1X2 | Poisoning by 4-Aminophenol derivatives, intentional self-harm |
| T39.1X3 | Poisoning by 4-Aminophenol derivatives, assault |
| T39.1X4 | Poisoning by 4-Aminophenol derivatives, undetermined |
| T40 | Poisoning by, adverse effect of and underdosing of narcotics and psychodysleptics [hallucinogens] |
| T40.2X5 | Adverse effect of other opioids |
| T42.4X5A | Adverse effect of benzodiazepines, initial encounter |
| T86 | Complications of transplanted organs and tissue |
| T86.4 | Complications of liver transplant |
| T86.40 | Unspecified complication of liver transplant |
| T86.41 | Liver transplant rejection |
| T86.42 | Liver transplant failure |
| T86.43 | Liver transplant infection |
| T86.49 | Other complications of liver transplant |
| Z00 | Encounter for general examination without complaint, suspected or reported diagnosis |
| Z00.0 | Encounter for general adult medical examination |
| Z00.00 | Encounter for general adult medical examination without abnormal findings |
| Z00.01 | Encounter for general adult medical examination with abnormal findings |
| Z00.8 | Encounter for other general examination |
| Z01.41 | Encounter for routine gynecological examination |
| Z01.411 | Encounter for gynecological examination (general) (routine) with abnormal findings |
| Z01.83 | Encounter for blood typing |
| Z01.84 | Encounter for antibody response examination |
| Z02 | Encounter for administrative examination |
| Z04 | Encounter for examination and observation for other reasons |
| Z11.1 | Encounter for screening for respiratory tuberculosis |
| Z11.5 | Encounter for screening for other viral diseases |
| Z11.59 | Encounter for screening for other viral diseases |
| Z12.10 | Encounter for screening for malignant neoplasm of intestinal tract, unspecified |
| Z13.1 | Encounter for screening for diabetes mellitus |
| Z13.220 | Encounter for screening for lipoid disorders |
| Z13.6 | Encounter for screening for cardiovascular disorders |
| Z16 | Resistance to antimicrobial drugs |
| Z20 | Contact with and (suspected) exposure to communicable diseases |
| Z20.5 | Contact with and (suspected) exposure to viral hepatitis |
| Z22.50 | |
| Z22.59 | |
| Z30.014 | Encounter for initial prescription of intrauterine contraceptive device |
| Z30.8 | Encounter for other contraceptive management |
| Z32.0 | Encounter for pregnancy test |
| Z33 | Pregnant state |
| Z34 | Encounter for supervision of normal pregnancy |
| Z34.0 | Encounter for supervision of normal first pregnancy |
| Z34.8 | Encounter for supervision of other normal pregnancy |
| Z34.9 | Encounter for supervision of normal pregnancy, unspecified |
| Z34.90 | Encounter for supervision of normal pregnancy, unspecified, unspecified trimester |
| Z36 | Encounter for antenatal screening of mother |
| Z36.0 | Encounter for antenatal screening for chromosomal anomalies |
| Z36.8 | Encounter for other antenatal screening |
| Z48.23 | Encounter for aftercare following liver transplant |
| Z51.81 | Encounter for therapeutic drug level monitoring |
| Z67 | Blood type |
| Z68 | Body mass index [BMI] |
| Z71.5 | Drug abuse counseling and surveillance |
| Z71.51 | Drug abuse counseling and surveillance of drug abuser |
| Z71.52 | Counseling for family member of drug abuser |
| Z77 | Other contact with and (suspected) exposures hazardous to health |
| Z77.120 | Contact with and (suspected) exposure to mold (toxic) |
| Z79 | Long term (current) drug therapy |
| Z79.1 | Long term (current) use of non-steroidal anti-inflammatories (NSAID) |
| Z79.52 | Long term (current) use of systemic steroids |
| Z79.89 | Other long term (current) drug therapy |
| Z79.890 | Hormone replacement therapy |
| Z79.891 | Long term (current) use of opiate analgesic |
| Z79.899 | Other long term (current) drug therapy |
| Z84 | Family history of other conditions |
| Z85 | Personal history of malignant neoplasm |
| Z85.05 | Personal history of malignant neoplasm of liver |
| Z85.09 | Personal history of malignant neoplasm of other digestive organs |
| Z85.72 | Personal history of non-Hodgkin lymphomas |
| Z86.11 | Personal history of tuberculosis |
| Z94.4 | Liver transplant status |
| A06.4 | Amebic liver abscess |
| A15.0 | Tuberculosis of lung |
| A15.4 | Tuberculosis of intrathoracic lymph nodes |
| A15.5 | Tuberculosis of larynx, trachea and bronchus |
| A15.6 | Tuberculous pleurisy |
| A15.7 | Primary respiratory tuberculosis |
| A15.8 | Other respiratory tuberculosis |
| A15.9 | Respiratory tuberculosis unspecified |
| A17.0 | Tuberculous meningitis |
| A17.1 | Meningeal tuberculoma |
| A17.8 | Other tuberculosis of nervous system |
| A17.81 | Tuberculoma of brain and spinal cord |
| A17.82 | Tuberculous meningoencephalitis |
| A17.83 | Tuberculous neuritis |
| A17.89 | Other tuberculosis of nervous system |
| A17.9 | Tuberculosis of nervous system, unspecified |
| A18.0 | Tuberculosis of bones and joints |
| A18.01 | Tuberculosis of spine |
| A18.02 | Tuberculous arthritis of other joints |
| A18.03 | Tuberculosis of other bones |
| A18.09 | Other musculoskeletal tuberculosis |
| A18.1 | Tuberculosis of genitourinary system |
| A18.10 | Tuberculosis of genitourinary system, unspecified |
| A18.11 | Tuberculosis of kidney and ureter |
| A18.12 | Tuberculosis of bladder |
| A18.13 | Tuberculosis of other urinary organs |
| A18.14 | Tuberculosis of prostate |
| A18.15 | Tuberculosis of other male genital organs |
| A18.16 | Tuberculosis of cervix |
| A18.17 | Tuberculous female pelvic inflammatory disease |
| A18.18 | Tuberculosis of other female genital organs |
| A18.2 | Tuberculous peripheral lymphadenopathy |
| A18.3 | Tuberculosis of intestines, peritoneum and mesenteric glands |
| A18.31 | Tuberculous peritonitis |
| A18.32 | Tuberculous enteritis |
| A18.39 | Retroperitoneal tuberculosis |
| A18.4 | Tuberculosis of skin and subcutaneous tissue |
| A18.5 | Tuberculosis of eye |
| A18.50 | Tuberculosis of eye, unspecified |
| A18.51 | Tuberculous episcleritis |
| A18.52 | Tuberculous keratitis |
| A18.53 | Tuberculous chorioretinitis |
| A18.54 | Tuberculous iridocyclitis |
| A18.59 | Other tuberculosis of eye |
| A18.6 | Tuberculosis of (inner) (middle) ear |
| A18.7 | Tuberculosis of adrenal glands |
| A18.8 | Tuberculosis of other specified organs |
| A18.81 | Tuberculosis of thyroid gland |
| A18.82 | Tuberculosis of other endocrine glands |
| A18.83 | Tuberculosis of digestive tract organs, not elsewhere classified |
| A18.84 | Tuberculosis of heart |
| A18.85 | Tuberculosis of spleen |
| A18.89 | Tuberculosis of other sites |
| A19.0 | Acute miliary tuberculosis of a single specified site |
| A19.1 | Acute miliary tuberculosis of multiple sites |
| A19.2 | Acute miliary tuberculosis, unspecified |
| A19.8 | Other miliary tuberculosis |
| A19.9 | Miliary tuberculosis, unspecified |
| A31.0 | Pulmonary mycobacterial infection |
| A31.1 | Cutaneous mycobacterial infection |
| A31.2 | Disseminated mycobacterium avium-intracellulare complex (DMAC) |
| A31.8 | Other mycobacterial infections |
| A31.9 | Mycobacterial infection, unspecified |
| A51.45 | Secondary syphilitic hepatitis |
| A52.04 | Syphilitic cerebral arteritis |
| B00.81 | Herpesviral hepatitis |
| B02.0 | Zoster encephalitis |
| B02.1 | Zoster meningitis |
| B02.2 | Zoster with other nervous system involvement |
| B02.21 | Postherpetic geniculate ganglionitis |
| B02.22 | Postherpetic trigeminal neuralgia |
| B02.23 | Postherpetic polyneuropathy |
| B02.24 | Postherpetic myelitis |
| B02.29 | Other postherpetic nervous system involvement |
| B02.3 | Zoster ocular disease |
| B02.30 | Zoster ocular disease, unspecified |
| B02.31 | Zoster conjunctivitis |
| B02.32 | Zoster iridocyclitis |
| B02.33 | Zoster keratitis |
| B02.34 | Zoster scleritis |
| B02.39 | Other herpes zoster eye disease |
| B02.7 | Disseminated zoster |
| B02.8 | Zoster with other complications |
| B02.9 | Zoster without complications |
| B15.0 | Hepatitis A with hepatic coma |
| B15.9 | Hepatitis A without hepatic coma |
| B16.0 | Acute hepatitis B with delta-agent with hepatic coma |
| B16.1 | Acute hepatitis B with delta-agent without hepatic coma |
| B16.2 | Acute hepatitis B without delta-agent with hepatic coma |
| B16.9 | Acute hepatitis B without delta-agent and without hepatic coma |
| B17.0 | Acute delta-(super) infection of hepatitis B carrier |
| B17.1 | Acute hepatitis C |
| B17.10 | Acute hepatitis C without hepatic coma |
| B17.11 | Acute hepatitis C with hepatic coma |
| B17.2 | Acute hepatitis E |
| B17.8 | Other specified acute viral hepatitis |
| B17.9 | Acute viral hepatitis, unspecified |
| B18.0 | Chronic viral hepatitis B with delta-agent |
| B18.1 | Chronic viral hepatitis B without delta-agent |
| B18.2 | Chronic viral hepatitis C |
| B18.8 | Other chronic viral hepatitis |
| B18.9 | Chronic viral hepatitis, unspecified |
| B19.0 | Unspecified viral hepatitis with hepatic coma |
| B19.1 | Unspecified viral hepatitis B |
| B19.10 | Unspecified viral hepatitis B without hepatic coma |
| B19.11 | Unspecified viral hepatitis B with hepatic coma |
| B19.2 | Unspecified viral hepatitis C |
| B19.20 | Unspecified viral hepatitis C without hepatic coma |
| B19.21 | Unspecified viral hepatitis C with hepatic coma |
| B19.9 | Unspecified viral hepatitis without hepatic coma |
| B25.1 | Cytomegaloviral hepatitis |
| B26.81 | Mumps hepatitis |
| B58.1 | Toxoplasma hepatitis |
| B90.0 | Sequelae of central nervous system tuberculosis |
| B90.1 | Sequelae of genitourinary tuberculosis |
| B90.2 | Sequelae of tuberculosis of bones and joints |
| B90.8 | Sequelae of tuberculosis of other organs |
| B90.9 | Sequelae of respiratory and unspecified tuberculosis |
| B94.2 | Sequelae of viral hepatitis |
| C22.0 | Liver cell carcinoma |
| C22.1 | Intrahepatic bile duct carcinoma |
| C22.2 | Hepatoblastoma |
| C22.3 | Angiosarcoma of liver |
| C22.4 | Other sarcomas of liver |
| C22.7 | Other specified carcinomas of liver |
| C22.8 | Malignant neoplasm of liver, primary, unspecified as to type |
| C22.9 | Malignant neoplasm of liver, not specified as primary or secondary |
| C24.0 | Malignant neoplasm of extrahepatic bile duct |
| C24.1 | Malignant neoplasm of ampulla of Vater |
| C24.8 | Malignant neoplasm of overlapping sites of biliary tract |
| C24.9 | Malignant neoplasm of biliary tract, unspecified |
| C77.0 | Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck |
| C77.1 | Secondary and unspecified malignant neoplasm of intrathoracic lymph nodes |
| C77.2 | Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes |
| C77.3 | Secondary and unspecified malignant neoplasm of axilla and upper limb lymph nodes |
| C77.4 | Secondary and unspecified malignant neoplasm of inguinal and lower limb lymph nodes |
| C77.5 | Secondary and unspecified malignant neoplasm of intrapelvic lymph nodes |
| C77.8 | Secondary and unspecified malignant neoplasm of lymph nodes of multiple regions |
| C77.9 | Secondary and unspecified malignant neoplasm of lymph node, unspecified |
| C78.7 | Secondary malignant neoplasm of liver and intrahepatic bile duct |
| C7B.02 | Secondary carcinoid tumors of liver |
| C82.0 | Follicular lymphoma grade I |
| C82.00 | Follicular lymphoma grade I, unspecified site |
| C82.01 | Follicular lymphoma grade I, lymph nodes of head, face, and neck |
| C82.02 | Follicular lymphoma grade I, intrathoracic lymph nodes |
| C82.03 | Follicular lymphoma grade I, intra-abdominal lymph nodes |
| C82.04 | Follicular lymphoma grade I, lymph nodes of axilla and upper limb |
| C82.05 | Follicular lymphoma grade I, lymph nodes of inguinal region and lower limb |
| C82.06 | Follicular lymphoma grade I, intrapelvic lymph nodes |
| C82.07 | Follicular lymphoma grade I, spleen |
| C82.08 | Follicular lymphoma grade I, lymph nodes of multiple sites |
| C82.09 | Follicular lymphoma grade I, extranodal and solid organ sites |
| C82.1 | Follicular lymphoma grade II |
| C82.10 | Follicular lymphoma grade II, unspecified site |
| C82.11 | Follicular lymphoma grade II, lymph nodes of head, face, and neck |
| C82.12 | Follicular lymphoma grade II, intrathoracic lymph nodes |
| C82.13 | Follicular lymphoma grade II, intra-abdominal lymph nodes |
| C82.14 | Follicular lymphoma grade II, lymph nodes of axilla and upper limb |
| C82.15 | Follicular lymphoma grade II, lymph nodes of inguinal region and lower limb |
| C82.16 | Follicular lymphoma grade II, intrapelvic lymph nodes |
| C82.17 | Follicular lymphoma grade II, spleen |
| C82.18 | Follicular lymphoma grade II, lymph nodes of multiple sites |
| C82.19 | Follicular lymphoma grade II, extranodal and solid organ sites |
| C82.2 | Follicular lymphoma grade III, unspecified |
| C82.20 | Follicular lymphoma grade III, unspecified, unspecified site |
| C82.21 | Follicular lymphoma grade III, unspecified, lymph nodes of head, face, and neck |
| C82.22 | Follicular lymphoma grade III, unspecified, intrathoracic lymph nodes |
| C82.23 | Follicular lymphoma grade III, unspecified, intra-abdominal lymph nodes |
| C82.24 | Follicular lymphoma grade III, unspecified, lymph nodes of axilla and upper limb |
| C82.25 | Follicular lymphoma grade III, unspecified, lymph nodes of inguinal region and lower limb |
| C82.26 | Follicular lymphoma grade III, unspecified, intrapelvic lymph nodes |
| C82.27 | Follicular lymphoma grade III, unspecified, spleen |
| C82.28 | Follicular lymphoma grade III, unspecified, lymph nodes of multiple sites |
| C82.29 | Follicular lymphoma grade III, unspecified, extranodal and solid organ sites |
| C82.3 | Follicular lymphoma grade IIIa |
| C82.30 | Follicular lymphoma grade IIIa, unspecified site |
| C82.31 | Follicular lymphoma grade IIIa, lymph nodes of head, face, and neck |
| C82.32 | Follicular lymphoma grade IIIa, intrathoracic lymph nodes |
| C82.33 | Follicular lymphoma grade IIIa, intra-abdominal lymph nodes |
| C82.34 | Follicular lymphoma grade IIIa, lymph nodes of axilla and upper limb |
| C82.35 | Follicular lymphoma grade IIIa, lymph nodes of inguinal region and lower limb |
| C82.36 | Follicular lymphoma grade IIIa, intrapelvic lymph nodes |
| C82.37 | Follicular lymphoma grade IIIa, spleen |
| C82.38 | Follicular lymphoma grade IIIa, lymph nodes of multiple sites |
| C82.39 | Follicular lymphoma grade IIIa, extranodal and solid organ sites |
| C82.4 | Follicular lymphoma grade IIIb |
| C82.40 | Follicular lymphoma grade IIIb, unspecified site |
| C82.41 | Follicular lymphoma grade IIIb, lymph nodes of head, face, and neck |
| C82.42 | Follicular lymphoma grade IIIb, intrathoracic lymph nodes |
| C82.43 | Follicular lymphoma grade IIIb, intra-abdominal lymph nodes |
| C82.44 | Follicular lymphoma grade IIIb, lymph nodes of axilla and upper limb |
| C82.45 | Follicular lymphoma grade IIIb, lymph nodes of inguinal region and lower limb |
| C82.46 | Follicular lymphoma grade IIIb, intrapelvic lymph nodes |
| C82.47 | Follicular lymphoma grade IIIb, spleen |
| C82.48 | Follicular lymphoma grade IIIb, lymph nodes of multiple sites |
| C82.49 | Follicular lymphoma grade IIIb, extranodal and solid organ sites |
| C82.5 | Diffuse follicle center lymphoma |
| C82.50 | Diffuse follicle center lymphoma, unspecified site |
| C82.51 | Diffuse follicle center lymphoma, lymph nodes of head, face, and neck |
| C82.52 | Diffuse follicle center lymphoma, intrathoracic lymph nodes |
| C82.53 | Diffuse follicle center lymphoma, intra-abdominal lymph nodes |
| C82.54 | Diffuse follicle center lymphoma, lymph nodes of axilla and upper limb |
| C82.55 | Diffuse follicle center lymphoma, lymph nodes of inguinal region and lower limb |
| C82.56 | Diffuse follicle center lymphoma, intrapelvic lymph nodes |
| C82.57 | Diffuse follicle center lymphoma, spleen |
| C82.58 | Diffuse follicle center lymphoma, lymph nodes of multiple sites |
| C82.59 | Diffuse follicle center lymphoma, extranodal and solid organ sites |
| C82.6 | Cutaneous follicle center lymphoma |
| C82.60 | Cutaneous follicle center lymphoma, unspecified site |
| C82.61 | Cutaneous follicle center lymphoma, lymph nodes of head, face, and neck |
| C82.62 | Cutaneous follicle center lymphoma, intrathoracic lymph nodes |
| C82.63 | Cutaneous follicle center lymphoma, intra-abdominal lymph nodes |
| C82.64 | Cutaneous follicle center lymphoma, lymph nodes of axilla and upper limb |
| C82.65 | Cutaneous follicle center lymphoma, lymph nodes of inguinal region and lower limb |
| C82.66 | Cutaneous follicle center lymphoma, intrapelvic lymph nodes |
| C82.67 | Cutaneous follicle center lymphoma, spleen |
| C82.68 | Cutaneous follicle center lymphoma, lymph nodes of multiple sites |
| C82.69 | Cutaneous follicle center lymphoma, extranodal and solid organ sites |
| C82.8 | Other types of follicular lymphoma |
| C82.80 | Other types of follicular lymphoma, unspecified site |
| C82.81 | Other types of follicular lymphoma, lymph nodes of head, face, and neck |
| C82.82 | Other types of follicular lymphoma, intrathoracic lymph nodes |
| C82.83 | Other types of follicular lymphoma, intra-abdominal lymph nodes |
| C82.84 | Other types of follicular lymphoma, lymph nodes of axilla and upper limb |
| C82.85 | Other types of follicular lymphoma, lymph nodes of inguinal region and lower limb |
| C82.86 | Other types of follicular lymphoma, intrapelvic lymph nodes |
| C82.87 | Other types of follicular lymphoma, spleen |
| C82.88 | Other types of follicular lymphoma, lymph nodes of multiple sites |
| C82.89 | Other types of follicular lymphoma, extranodal and solid organ sites |
| C82.9 | Follicular lymphoma, unspecified |
| C82.90 | Follicular lymphoma, unspecified, unspecified site |
| C82.91 | Follicular lymphoma, unspecified, lymph nodes of head, face, and neck |
| C82.92 | Follicular lymphoma, unspecified, intrathoracic lymph nodes |
| C82.93 | Follicular lymphoma, unspecified, intra-abdominal lymph nodes |
| C82.94 | Follicular lymphoma, unspecified, lymph nodes of axilla and upper limb |
| C82.95 | Follicular lymphoma, unspecified, lymph nodes of inguinal region and lower limb |
| C82.96 | Follicular lymphoma, unspecified, intrapelvic lymph nodes |
| C82.97 | Follicular lymphoma, unspecified, spleen |
| C82.98 | Follicular lymphoma, unspecified, lymph nodes of multiple sites |
| C82.99 | Follicular lymphoma, unspecified, extranodal and solid organ sites |
| C83.0 | Small cell B-cell lymphoma |
| C83.00 | Small cell B-cell lymphoma, unspecified site |
| C83.01 | Small cell B-cell lymphoma, lymph nodes of head, face, and neck |
| C83.02 | Small cell B-cell lymphoma, intrathoracic lymph nodes |
| C83.03 | Small cell B-cell lymphoma, intra-abdominal lymph nodes |
| C83.04 | Small cell B-cell lymphoma, lymph nodes of axilla and upper limb |
| C83.05 | Small cell B-cell lymphoma, lymph nodes of inguinal region and lower limb |
| C83.06 | Small cell B-cell lymphoma, intrapelvic lymph nodes |
| C83.07 | Small cell B-cell lymphoma, spleen |
| C83.08 | Small cell B-cell lymphoma, lymph nodes of multiple sites |
| C83.09 | Small cell B-cell lymphoma, extranodal and solid organ sites |
| C83.1 | Mantle cell lymphoma |
| C83.10 | Mantle cell lymphoma, unspecified site |
| C83.11 | Mantle cell lymphoma, lymph nodes of head, face, and neck |
| C83.12 | Mantle cell lymphoma, intrathoracic lymph nodes |
| C83.13 | Mantle cell lymphoma, intra-abdominal lymph nodes |
| C83.14 | Mantle cell lymphoma, lymph nodes of axilla and upper limb |
| C83.15 | Mantle cell lymphoma, lymph nodes of inguinal region and lower limb |
| C83.16 | Mantle cell lymphoma, intrapelvic lymph nodes |
| C83.17 | Mantle cell lymphoma, spleen |
| C83.18 | Mantle cell lymphoma, lymph nodes of multiple sites |
| C83.19 | Mantle cell lymphoma, extranodal and solid organ sites |
| C83.3 | Diffuse large B-cell lymphoma |
| C83.30 | Diffuse large B-cell lymphoma, unspecified site |
| C83.31 | Diffuse large B-cell lymphoma, lymph nodes of head, face, and neck |
| C83.32 | Diffuse large B-cell lymphoma, intrathoracic lymph nodes |
| C83.33 | Diffuse large B-cell lymphoma, intra-abdominal lymph nodes |
| C83.34 | Diffuse large B-cell lymphoma, lymph nodes of axilla and upper limb |
| C83.35 | Diffuse large B-cell lymphoma, lymph nodes of inguinal region and lower limb |
| C83.36 | Diffuse large B-cell lymphoma, intrapelvic lymph nodes |
| C83.37 | Diffuse large B-cell lymphoma, spleen |
| C83.38 | Diffuse large B-cell lymphoma, lymph nodes of multiple sites |
| C83.39 | Diffuse large B-cell lymphoma, extranodal and solid organ sites |
| C83.5 | Lymphoblastic (diffuse) lymphoma |
| C83.50 | Lymphoblastic (diffuse) lymphoma, unspecified site |
| C83.51 | Lymphoblastic (diffuse) lymphoma, lymph nodes of head, face, and neck |
| C83.52 | Lymphoblastic (diffuse) lymphoma, intrathoracic lymph nodes |
| C83.53 | Lymphoblastic (diffuse) lymphoma, intra-abdominal lymph nodes |
| C83.54 | Lymphoblastic (diffuse) lymphoma, lymph nodes of axilla and upper limb |
| C83.55 | Lymphoblastic (diffuse) lymphoma, lymph nodes of inguinal region and lower limb |
| C83.56 | Lymphoblastic (diffuse) lymphoma, intrapelvic lymph nodes |
| C83.57 | Lymphoblastic (diffuse) lymphoma, spleen |
| C83.58 | Lymphoblastic (diffuse) lymphoma, lymph nodes of multiple sites |
| C83.59 | Lymphoblastic (diffuse) lymphoma, extranodal and solid organ sites |
| C83.7 | Burkitt lymphoma |
| C83.70 | Burkitt lymphoma, unspecified site |
| C83.71 | Burkitt lymphoma, lymph nodes of head, face, and neck |
| C83.72 | Burkitt lymphoma, intrathoracic lymph nodes |
| C83.73 | Burkitt lymphoma, intra-abdominal lymph nodes |
| C83.74 | Burkitt lymphoma, lymph nodes of axilla and upper limb |
| C83.75 | Burkitt lymphoma, lymph nodes of inguinal region and lower limb |
| C83.76 | Burkitt lymphoma, intrapelvic lymph nodes |
| C83.77 | Burkitt lymphoma, spleen |
| C83.78 | Burkitt lymphoma, lymph nodes of multiple sites |
| C83.79 | Burkitt lymphoma, extranodal and solid organ sites |
| C83.8 | Other non-follicular lymphoma |
| C83.80 | Other non-follicular lymphoma, unspecified site |
| C83.81 | Other non-follicular lymphoma, lymph nodes of head, face, and neck |
| C83.82 | Other non-follicular lymphoma, intrathoracic lymph nodes |
| C83.83 | Other non-follicular lymphoma, intra-abdominal lymph nodes |
| C83.84 | Other non-follicular lymphoma, lymph nodes of axilla and upper limb |
| C83.85 | Other non-follicular lymphoma, lymph nodes of inguinal region and lower limb |
| C83.86 | Other non-follicular lymphoma, intrapelvic lymph nodes |
| C83.87 | Other non-follicular lymphoma, spleen |
| C83.88 | Other non-follicular lymphoma, lymph nodes of multiple sites |
| C83.89 | Other non-follicular lymphoma, extranodal and solid organ sites |
| C83.9 | Non-follicular (diffuse) lymphoma, unspecified |
| C83.90 | Non-follicular (diffuse) lymphoma, unspecified, unspecified site |
| C83.91 | Non-follicular (diffuse) lymphoma, unspecified, lymph nodes of head, face, and neck |
| C83.92 | Non-follicular (diffuse) lymphoma, unspecified, intrathoracic lymph nodes |
| C83.93 | Non-follicular (diffuse) lymphoma, unspecified, intra-abdominal lymph nodes |
| C83.94 | Non-follicular (diffuse) lymphoma, unspecified, lymph nodes of axilla and upper limb |
| C83.95 | Non-follicular (diffuse) lymphoma, unspecified, lymph nodes of inguinal region and lower limb |
| C83.96 | Non-follicular (diffuse) lymphoma, unspecified, intrapelvic lymph nodes |
| C83.97 | Non-follicular (diffuse) lymphoma, unspecified, spleen |
| C83.98 | Non-follicular (diffuse) lymphoma, unspecified, lymph nodes of multiple sites |
| C83.99 | Non-follicular (diffuse) lymphoma, unspecified, extranodal and solid organ sites |
| C85.1 | Unspecified B-cell lymphoma |
| C85.10 | Unspecified B-cell lymphoma, unspecified site |
| C85.11 | Unspecified B-cell lymphoma, lymph nodes of head, face, and neck |
| C85.12 | Unspecified B-cell lymphoma, intrathoracic lymph nodes |
| C85.13 | Unspecified B-cell lymphoma, intra-abdominal lymph nodes |
| C85.14 | Unspecified B-cell lymphoma, lymph nodes of axilla and upper limb |
| C85.15 | Unspecified B-cell lymphoma, lymph nodes of inguinal region and lower limb |
| C85.16 | Unspecified B-cell lymphoma, intrapelvic lymph nodes |
| C85.17 | Unspecified B-cell lymphoma, spleen |
| C85.18 | Unspecified B-cell lymphoma, lymph nodes of multiple sites |
| C85.19 | Unspecified B-cell lymphoma, extranodal and solid organ sites |
| C85.2 | Mediastinal (thymic) large B-cell lymphoma |
| C85.20 | Mediastinal (thymic) large B-cell lymphoma, unspecified site |
| C85.21 | Mediastinal (thymic) large B-cell lymphoma, lymph nodes of head, face, and neck |
| C85.22 | Mediastinal (thymic) large B-cell lymphoma, intrathoracic lymph nodes |
| C85.23 | Mediastinal (thymic) large B-cell lymphoma, intra-abdominal lymph nodes |
| C85.24 | Mediastinal (thymic) large B-cell lymphoma, lymph nodes of axilla and upper limb |
| C85.25 | Mediastinal (thymic) large B-cell lymphoma, lymph nodes of inguinal region and lower limb |
| C85.26 | Mediastinal (thymic) large B-cell lymphoma, intrapelvic lymph nodes |
| C85.27 | Mediastinal (thymic) large B-cell lymphoma, spleen |
| C85.28 | Mediastinal (thymic) large B-cell lymphoma, lymph nodes of multiple sites |
| C85.29 | Mediastinal (thymic) large B-cell lymphoma, extranodal and solid organ sites |
| C85.8 | Other specified types of non-Hodgkin lymphoma |
| C85.80 | Other specified types of non-Hodgkin lymphoma, unspecified site |
| C85.81 | Other specified types of non-Hodgkin lymphoma, lymph nodes of head, face, and neck |
| C85.82 | Other specified types of non-Hodgkin lymphoma, intrathoracic lymph nodes |
| C85.83 | Other specified types of non-Hodgkin lymphoma, intra-abdominal lymph nodes |
| C85.84 | Other specified types of non-Hodgkin lymphoma, lymph nodes of axilla and upper limb |
| C85.85 | Other specified types of non-Hodgkin lymphoma, lymph nodes of inguinal region and lower limb |
| C85.86 | Other specified types of non-Hodgkin lymphoma, intrapelvic lymph nodes |
| C85.87 | Other specified types of non-Hodgkin lymphoma, spleen |
| C85.88 | Other specified types of non-Hodgkin lymphoma, lymph nodes of multiple sites |
| C85.89 | Other specified types of non-Hodgkin lymphoma, extranodal and solid organ sites |
| C85.9 | Non-Hodgkin lymphoma, unspecified |
| C85.90 | Non-Hodgkin lymphoma, unspecified, unspecified site |
| C85.91 | Non-Hodgkin lymphoma, unspecified, lymph nodes of head, face, and neck |
| C85.92 | Non-Hodgkin lymphoma, unspecified, intrathoracic lymph nodes |
| C85.93 | Non-Hodgkin lymphoma, unspecified, intra-abdominal lymph nodes |
| C85.94 | Non-Hodgkin lymphoma, unspecified, lymph nodes of axilla and upper limb |
| C85.95 | Non-Hodgkin lymphoma, unspecified, lymph nodes of inguinal region and lower limb |
| C85.96 | Non-Hodgkin lymphoma, unspecified, intrapelvic lymph nodes |
| C85.97 | Non-Hodgkin lymphoma, unspecified, spleen |
| C85.98 | Non-Hodgkin lymphoma, unspecified, lymph nodes of multiple sites |
| C85.99 | Non-Hodgkin lymphoma, unspecified, extranodal and solid organ sites |
| C88.0 | Waldenstrom macroglobulinemia |
| C88.2 | Heavy chain disease |
| C88.3 | Immunoproliferative small intestinal disease |
| C88.4 | Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma] |
| C88.8 | Other malignant immunoproliferative diseases |
| C88.9 | Malignant immunoproliferative disease, unspecified |
| D01.5 | Carcinoma in situ of liver, gallbladder and bile ducts |
| D13.0 | Benign neoplasm of esophagus |
| D13.1 | Benign neoplasm of stomach |
| D13.2 | Benign neoplasm of duodenum |
| D13.3 | Benign neoplasm of other and unspecified parts of small intestine |
| D13.30 | Benign neoplasm of unspecified part of small intestine |
| D13.39 | Benign neoplasm of other parts of small intestine |
| D13.4 | Benign neoplasm of liver |
| D13.5 | Benign neoplasm of extrahepatic bile ducts |
| D13.6 | Benign neoplasm of pancreas |
| D13.7 | Benign neoplasm of endocrine pancreas |
| D13.9 | Benign neoplasm of ill-defined sites within the digestive system |
| D37.6 | Neoplasm of uncertain behavior of liver, gallbladder and bile ducts |
| D69.0 | Allergic purpura |
| D69.1 | Qualitative platelet defects |
| D69.2 | Other nonthrombocytopenic purpura |
| D69.3 | Immune thrombocytopenic purpura |
| D69.4 | Other primary thrombocytopenia |
| D69.41 | Evans syndrome |
| D69.42 | Congenital and hereditary thrombocytopenia purpura |
| D69.49 | Other primary thrombocytopenia |
| D69.5 | Secondary thrombocytopenia |
| D69.51 | Posttransfusion purpura |
| D69.59 | Other secondary thrombocytopenia |
| D69.6 | Thrombocytopenia, unspecified |
| D69.8 | Other specified hemorrhagic conditions |
| D69.9 | Hemorrhagic condition, unspecified |
| D89.0 | Polyclonal hypergammaglobulinemia |
| D89.1 | Cryoglobulinemia |
| D89.2 | Hypergammaglobulinemia, unspecified |
| D89.3 | Immune reconstitution syndrome |
| D89.4 | Mast cell activation syndrome and related disorders |
| D89.40 | Mast cell activation, unspecified |
| D89.41 | Monoclonal mast cell activation syndrome |
| D89.42 | Idiopathic mast cell activation syndrome |
| D89.43 | Secondary mast cell activation |
| D89.49 | Other mast cell activation disorder |
| D89.8 | Other specified disorders involving the immune mechanism, not elsewhere classified |
| D89.81 | Graft-versus-host disease |
| D89.810 | Acute graft-versus-host disease |
| D89.811 | Chronic graft-versus-host disease |
| D89.812 | Acute on chronic graft-versus-host disease |
| D89.813 | Graft-versus-host disease, unspecified |
| D89.82 | Autoimmune lymphoproliferative syndrome [ALPS] |
| D89.83 | Cytokine release syndrome |
| D89.831 | Cytokine release syndrome, grade 1 |
| D89.832 | Cytokine release syndrome, grade 2 |
| D89.833 | Cytokine release syndrome, grade 3 |
| D89.834 | Cytokine release syndrome, grade 4 |
| D89.835 | Cytokine release syndrome, grade 5 |
| D89.839 | Cytokine release syndrome, grade unspecified |
| D89.89 | Other specified disorders involving the immune mechanism, not elsewhere classified |
| D89.9 | Disorder involving the immune mechanism, unspecified |
| E10.40 | Type 1 diabetes mellitus with diabetic neuropathy, unspecified |
| E11.40 | Type 2 diabetes mellitus with diabetic neuropathy, unspecified |
| F11.1 | Opioid abuse |
| F11.10 | Opioid abuse, uncomplicated |
| F11.11 | Opioid abuse, in remission |
| F11.12 | Opioid abuse with intoxication |
| F11.120 | Opioid abuse with intoxication, uncomplicated |
| F11.121 | Opioid abuse with intoxication delirium |
| F11.122 | Opioid abuse with intoxication with perceptual disturbance |
| F11.129 | Opioid abuse with intoxication, unspecified |
| F11.13 | Opioid abuse with withdrawal |
| F11.14 | Opioid abuse with opioid-induced mood disorder |
| F11.15 | Opioid abuse with opioid-induced psychotic disorder |
| F11.150 | Opioid abuse with opioid-induced psychotic disorder with delusions |
| F11.151 | Opioid abuse with opioid-induced psychotic disorder with hallucinations |
| F11.159 | Opioid abuse with opioid-induced psychotic disorder, unspecified |
| F11.18 | Opioid abuse with other opioid-induced disorder |
| F11.181 | Opioid abuse with opioid-induced sexual dysfunction |
| F11.182 | Opioid abuse with opioid-induced sleep disorder |
| F11.188 | Opioid abuse with other opioid-induced disorder |
| F11.19 | Opioid abuse with unspecified opioid-induced disorder |
| F11.2 | Opioid dependence |
| F11.20 | Opioid dependence, uncomplicated |
| F11.21 | Opioid dependence, in remission |
| F11.22 | Opioid dependence with intoxication |
| F11.220 | Opioid dependence with intoxication, uncomplicated |
| F11.221 | Opioid dependence with intoxication delirium |
| F11.222 | Opioid dependence with intoxication with perceptual disturbance |
| F11.229 | Opioid dependence with intoxication, unspecified |
| F11.23 | Opioid dependence with withdrawal |
| F11.24 | Opioid dependence with opioid-induced mood disorder |
| F11.25 | Opioid dependence with opioid-induced psychotic disorder |
| F11.250 | Opioid dependence with opioid-induced psychotic disorder with delusions |
| F11.251 | Opioid dependence with opioid-induced psychotic disorder with hallucinations |
| F11.259 | Opioid dependence with opioid-induced psychotic disorder, unspecified |
| F11.28 | Opioid dependence with other opioid-induced disorder |
| F11.281 | Opioid dependence with opioid-induced sexual dysfunction |
| F11.282 | Opioid dependence with opioid-induced sleep disorder |
| F11.288 | Opioid dependence with other opioid-induced disorder |
| F11.29 | Opioid dependence with unspecified opioid-induced disorder |
| F11.9 | Opioid use, unspecified |
| F11.90 | Opioid use, unspecified, uncomplicated |
| F11.92 | Opioid use, unspecified with intoxication |
| F11.920 | Opioid use, unspecified with intoxication, uncomplicated |
| F11.921 | Opioid use, unspecified with intoxication delirium |
| F11.922 | Opioid use, unspecified with intoxication with perceptual disturbance |
| F11.929 | Opioid use, unspecified with intoxication, unspecified |
| F11.93 | Opioid use, unspecified with withdrawal |
| F11.94 | Opioid use, unspecified with opioid-induced mood disorder |
| F11.95 | Opioid use, unspecified with opioid-induced psychotic disorder |
| F11.950 | Opioid use, unspecified with opioid-induced psychotic disorder with delusions |
| F11.951 | Opioid use, unspecified with opioid-induced psychotic disorder with hallucinations |
| F11.959 | Opioid use, unspecified with opioid-induced psychotic disorder, unspecified |
| F11.98 | Opioid use, unspecified with other specified opioid-induced disorder |
| F11.981 | Opioid use, unspecified with opioid-induced sexual dysfunction |
| F11.982 | Opioid use, unspecified with opioid-induced sleep disorder |
| F11.988 | Opioid use, unspecified with other opioid-induced disorder |
| F11.99 | Opioid use, unspecified with unspecified opioid-induced disorder |
| F12.1 | Cannabis abuse |
| F12.10 | Cannabis abuse, uncomplicated |
| F12.11 | Cannabis abuse, in remission |
| F12.12 | Cannabis abuse with intoxication |
| F12.120 | Cannabis abuse with intoxication, uncomplicated |
| F12.121 | Cannabis abuse with intoxication delirium |
| F12.122 | Cannabis abuse with intoxication with perceptual disturbance |
| F12.129 | Cannabis abuse with intoxication, unspecified |
| F12.13 | Cannabis abuse with withdrawal |
| F12.15 | Cannabis abuse with psychotic disorder |
| F12.150 | Cannabis abuse with psychotic disorder with delusions |
| F12.151 | Cannabis abuse with psychotic disorder with hallucinations |
| F12.159 | Cannabis abuse with psychotic disorder, unspecified |
| F12.18 | Cannabis abuse with other cannabis-induced disorder |
| F12.180 | Cannabis abuse with cannabis-induced anxiety disorder |
| F12.188 | Cannabis abuse with other cannabis-induced disorder |
| F12.19 | Cannabis abuse with unspecified cannabis-induced disorder |
| F12.2 | Cannabis dependence |
| F12.20 | Cannabis dependence, uncomplicated |
| F12.21 | Cannabis dependence, in remission |
| F12.22 | Cannabis dependence with intoxication |
| F12.220 | Cannabis dependence with intoxication, uncomplicated |
| F12.221 | Cannabis dependence with intoxication delirium |
| F12.222 | Cannabis dependence with intoxication with perceptual disturbance |
| F12.229 | Cannabis dependence with intoxication, unspecified |
| F12.23 | Cannabis dependence with withdrawal |
| F12.25 | Cannabis dependence with psychotic disorder |
| F12.250 | Cannabis dependence with psychotic disorder with delusions |
| F12.251 | Cannabis dependence with psychotic disorder with hallucinations |
| F12.259 | Cannabis dependence with psychotic disorder, unspecified |
| F12.28 | Cannabis dependence with other cannabis-induced disorder |
| F12.280 | Cannabis dependence with cannabis-induced anxiety disorder |
| F12.288 | Cannabis dependence with other cannabis-induced disorder |
| F12.29 | Cannabis dependence with unspecified cannabis-induced disorder |
| F12.9 | Cannabis use, unspecified |
| F12.90 | Cannabis use, unspecified, uncomplicated |
| F12.92 | Cannabis use, unspecified with intoxication |
| F12.920 | Cannabis use, unspecified with intoxication, uncomplicated |
| F12.921 | Cannabis use, unspecified with intoxication delirium |
| F12.922 | Cannabis use, unspecified with intoxication with perceptual disturbance |
| F12.929 | Cannabis use, unspecified with intoxication, unspecified |
| F12.93 | Cannabis use, unspecified with withdrawal |
| F12.95 | Cannabis use, unspecified with psychotic disorder |
| F12.950 | Cannabis use, unspecified with psychotic disorder with delusions |
| F12.951 | Cannabis use, unspecified with psychotic disorder with hallucinations |
| F12.959 | Cannabis use, unspecified with psychotic disorder, unspecified |
| F12.98 | Cannabis use, unspecified with other cannabis-induced disorder |
| F12.980 | Cannabis use, unspecified with anxiety disorder |
| F12.988 | Cannabis use, unspecified with other cannabis-induced disorder |
| F12.99 | Cannabis use, unspecified with unspecified cannabis-induced disorder |
| F13.1 | Sedative, hypnotic or anxiolytic-related abuse |
| F13.10 | Sedative, hypnotic or anxiolytic abuse, uncomplicated |
| F13.11 | Sedative, hypnotic or anxiolytic abuse, in remission |
| F13.12 | Sedative, hypnotic or anxiolytic abuse with intoxication |
| F13.120 | Sedative, hypnotic or anxiolytic abuse with intoxication, uncomplicated |
| F13.121 | Sedative, hypnotic or anxiolytic abuse with intoxication delirium |
| F13.129 | Sedative, hypnotic or anxiolytic abuse with intoxication, unspecified |
| F13.13 | Sedative, hypnotic or anxiolytic abuse with withdrawal |
| F13.130 | Sedative, hypnotic or anxiolytic abuse with withdrawal, uncomplicated |
| F13.131 | Sedative, hypnotic or anxiolytic abuse with withdrawal delirium |
| F13.132 | Sedative, hypnotic or anxiolytic abuse with withdrawal with perceptual disturbance |
| F13.139 | Sedative, hypnotic or anxiolytic abuse with withdrawal, unspecified |
| F13.14 | Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced mood disorder |
| F13.15 | Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced psychotic disorder |
| F13.150 | Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced psychotic disorder with delusions |
| F13.151 | Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced psychotic disorder with hallucinations |
| F13.159 | Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced psychotic disorder, unspecified |
| F13.18 | Sedative, hypnotic or anxiolytic abuse with other sedative, hypnotic or anxiolytic-induced disorders |
| F13.180 | Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced anxiety disorder |
| F13.181 | Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced sexual dysfunction |
| F13.182 | Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced sleep disorder |
| F13.188 | Sedative, hypnotic or anxiolytic abuse with other sedative, hypnotic or anxiolytic-induced disorder |
| F13.19 | Sedative, hypnotic or anxiolytic abuse with unspecified sedative, hypnotic or anxiolytic-induced disorder |
| F13.2 | Sedative, hypnotic or anxiolytic-related dependence |
| F13.20 | Sedative, hypnotic or anxiolytic dependence, uncomplicated |
| F13.21 | Sedative, hypnotic or anxiolytic dependence, in remission |
| F13.22 | Sedative, hypnotic or anxiolytic dependence with intoxication |
| F13.220 | Sedative, hypnotic or anxiolytic dependence with intoxication, uncomplicated |
| F13.221 | Sedative, hypnotic or anxiolytic dependence with intoxication delirium |
| F13.229 | Sedative, hypnotic or anxiolytic dependence with intoxication, unspecified |
| F13.23 | Sedative, hypnotic or anxiolytic dependence with withdrawal |
| F13.230 | Sedative, hypnotic or anxiolytic dependence with withdrawal, uncomplicated |
| F13.231 | Sedative, hypnotic or anxiolytic dependence with withdrawal delirium |
| F13.232 | Sedative, hypnotic or anxiolytic dependence with withdrawal with perceptual disturbance |
| F13.239 | Sedative, hypnotic or anxiolytic dependence with withdrawal, unspecified |
| F13.24 | Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced mood disorder |
| F13.25 | Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced psychotic disorder |
| F13.250 | Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced psychotic disorder with delusions |
| F13.251 | Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced psychotic disorder with hallucinations |
| F13.259 | Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced psychotic disorder, unspecified |
| F13.26 | Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced persisting amnestic disorder |
| F13.27 | Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced persisting dementia |
| F13.28 | Sedative, hypnotic or anxiolytic dependence with other sedative, hypnotic or anxiolytic-induced disorders |
| F13.280 | Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced anxiety disorder |
| F13.281 | Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced sexual dysfunction |
| F13.282 | Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced sleep disorder |
| F13.288 | Sedative, hypnotic or anxiolytic dependence with other sedative, hypnotic or anxiolytic-induced disorder |
| F13.29 | Sedative, hypnotic or anxiolytic dependence with unspecified sedative, hypnotic or anxiolytic-induced disorder |
| F13.9 | Sedative, hypnotic or anxiolytic-related use, unspecified |
| F13.90 | Sedative, hypnotic, or anxiolytic use, unspecified, uncomplicated |
| F13.92 | Sedative, hypnotic or anxiolytic use, unspecified with intoxication |
| F13.920 | Sedative, hypnotic or anxiolytic use, unspecified with intoxication, uncomplicated |
| F13.921 | Sedative, hypnotic or anxiolytic use, unspecified with intoxication delirium |
| F13.929 | Sedative, hypnotic or anxiolytic use, unspecified with intoxication, unspecified |
| F13.93 | Sedative, hypnotic or anxiolytic use, unspecified with withdrawal |
| F13.930 | Sedative, hypnotic or anxiolytic use, unspecified with withdrawal, uncomplicated |
| F13.931 | Sedative, hypnotic or anxiolytic use, unspecified with withdrawal delirium |
| F13.932 | Sedative, hypnotic or anxiolytic use, unspecified with withdrawal with perceptual disturbances |
| F13.939 | Sedative, hypnotic or anxiolytic use, unspecified with withdrawal, unspecified |
| F13.94 | Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced mood disorder |
| F13.95 | Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced psychotic disorder |
| F13.950 | Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced psychotic disorder with delusions |
| F13.951 | Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced psychotic disorder with hallucinations |
| F13.959 | Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced psychotic disorder, unspecified |
| F13.96 | Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced persisting amnestic disorder |
| F13.97 | Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced persisting dementia |
| F13.98 | Sedative, hypnotic or anxiolytic use, unspecified with other sedative, hypnotic or anxiolytic-induced disorders |
| F13.980 | Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced anxiety disorder |
| F13.981 | Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced sexual dysfunction |
| F13.982 | Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced sleep disorder |
| F13.988 | Sedative, hypnotic or anxiolytic use, unspecified with other sedative, hypnotic or anxiolytic-induced disorder |
| F13.99 | Sedative, hypnotic or anxiolytic use, unspecified with unspecified sedative, hypnotic or anxiolytic-induced disorder |
| F14.1 | Cocaine abuse |
| F14.10 | Cocaine abuse, uncomplicated |
| F14.11 | Cocaine abuse, in remission |
| F14.12 | Cocaine abuse with intoxication |
| F14.120 | Cocaine abuse with intoxication, uncomplicated |
| F14.121 | Cocaine abuse with intoxication with delirium |
| F14.122 | Cocaine abuse with intoxication with perceptual disturbance |
| F14.129 | Cocaine abuse with intoxication, unspecified |
| F14.13 | Cocaine abuse, unspecified with withdrawal |
| F14.14 | Cocaine abuse with cocaine-induced mood disorder |
| F14.15 | Cocaine abuse with cocaine-induced psychotic disorder |
| F14.150 | Cocaine abuse with cocaine-induced psychotic disorder with delusions |
| F14.151 | Cocaine abuse with cocaine-induced psychotic disorder with hallucinations |
| F14.159 | Cocaine abuse with cocaine-induced psychotic disorder, unspecified |
| F14.18 | Cocaine abuse with other cocaine-induced disorder |
| F14.180 | Cocaine abuse with cocaine-induced anxiety disorder |
| F14.181 | Cocaine abuse with cocaine-induced sexual dysfunction |
| F14.182 | Cocaine abuse with cocaine-induced sleep disorder |
| F14.188 | Cocaine abuse with other cocaine-induced disorder |
| F14.19 | Cocaine abuse with unspecified cocaine-induced disorder |
| F14.2 | Cocaine dependence |
| F14.20 | Cocaine dependence, uncomplicated |
| F14.21 | Cocaine dependence, in remission |
| F14.22 | Cocaine dependence with intoxication |
| F14.220 | Cocaine dependence with intoxication, uncomplicated |
| F14.221 | Cocaine dependence with intoxication delirium |
| F14.222 | Cocaine dependence with intoxication with perceptual disturbance |
| F14.229 | Cocaine dependence with intoxication, unspecified |
| F14.23 | Cocaine dependence with withdrawal |
| F14.24 | Cocaine dependence with cocaine-induced mood disorder |
| F14.25 | Cocaine dependence with cocaine-induced psychotic disorder |
| F14.250 | Cocaine dependence with cocaine-induced psychotic disorder with delusions |
| F14.251 | Cocaine dependence with cocaine-induced psychotic disorder with hallucinations |
| F14.259 | Cocaine dependence with cocaine-induced psychotic disorder, unspecified |
| F14.28 | Cocaine dependence with other cocaine-induced disorder |
| F14.280 | Cocaine dependence with cocaine-induced anxiety disorder |
| F14.281 | Cocaine dependence with cocaine-induced sexual dysfunction |
| F14.282 | Cocaine dependence with cocaine-induced sleep disorder |
| F14.288 | Cocaine dependence with other cocaine-induced disorder |
| F14.29 | Cocaine dependence with unspecified cocaine-induced disorder |
| F14.9 | Cocaine use, unspecified |
| F14.90 | Cocaine use, unspecified, uncomplicated |
| F14.92 | Cocaine use, unspecified with intoxication |
| F14.920 | Cocaine use, unspecified with intoxication, uncomplicated |
| F14.921 | Cocaine use, unspecified with intoxication delirium |
| F14.922 | Cocaine use, unspecified with intoxication with perceptual disturbance |
| F14.929 | Cocaine use, unspecified with intoxication, unspecified |
| F14.93 | Cocaine use, unspecified with withdrawal |
| F14.94 | Cocaine use, unspecified with cocaine-induced mood disorder |
| F14.95 | Cocaine use, unspecified with cocaine-induced psychotic disorder |
| F14.950 | Cocaine use, unspecified with cocaine-induced psychotic disorder with delusions |
| F14.951 | Cocaine use, unspecified with cocaine-induced psychotic disorder with hallucinations |
| F14.959 | Cocaine use, unspecified with cocaine-induced psychotic disorder, unspecified |
| F14.98 | Cocaine use, unspecified with other specified cocaine-induced disorder |
| F14.980 | Cocaine use, unspecified with cocaine-induced anxiety disorder |
| F14.981 | Cocaine use, unspecified with cocaine-induced sexual dysfunction |
| F14.982 | Cocaine use, unspecified with cocaine-induced sleep disorder |
| F14.988 | Cocaine use, unspecified with other cocaine-induced disorder |
| F14.99 | Cocaine use, unspecified with unspecified cocaine-induced disorder |
| F15.1 | Other stimulant abuse |
| F15.10 | Other stimulant abuse, uncomplicated |
| F15.11 | Other stimulant abuse, in remission |
| F15.12 | Other stimulant abuse with intoxication |
| F15.120 | Other stimulant abuse with intoxication, uncomplicated |
| F15.121 | Other stimulant abuse with intoxication delirium |
| F15.122 | Other stimulant abuse with intoxication with perceptual disturbance |
| F15.129 | Other stimulant abuse with intoxication, unspecified |
| F15.13 | Other stimulant abuse with withdrawal |
| F15.14 | Other stimulant abuse with stimulant-induced mood disorder |
| F15.15 | Other stimulant abuse with stimulant-induced psychotic disorder |
| F15.150 | Other stimulant abuse with stimulant-induced psychotic disorder with delusions |
| F15.151 | Other stimulant abuse with stimulant-induced psychotic disorder with hallucinations |
| F15.159 | Other stimulant abuse with stimulant-induced psychotic disorder, unspecified |
| F15.18 | Other stimulant abuse with other stimulant-induced disorder |
| F15.180 | Other stimulant abuse with stimulant-induced anxiety disorder |
| F15.181 | Other stimulant abuse with stimulant-induced sexual dysfunction |
| F15.182 | Other stimulant abuse with stimulant-induced sleep disorder |
| F15.188 | Other stimulant abuse with other stimulant-induced disorder |
| F15.19 | Other stimulant abuse with unspecified stimulant-induced disorder |
| F15.2 | Other stimulant dependence |
| F15.20 | Other stimulant dependence, uncomplicated |
| F15.21 | Other stimulant dependence, in remission |
| F15.22 | Other stimulant dependence with intoxication |
| F15.220 | Other stimulant dependence with intoxication, uncomplicated |
| F15.221 | Other stimulant dependence with intoxication delirium |
| F15.222 | Other stimulant dependence with intoxication with perceptual disturbance |
| F15.229 | Other stimulant dependence with intoxication, unspecified |
| F15.23 | Other stimulant dependence with withdrawal |
| F15.24 | Other stimulant dependence with stimulant-induced mood disorder |
| F15.25 | Other stimulant dependence with stimulant-induced psychotic disorder |
| F15.250 | Other stimulant dependence with stimulant-induced psychotic disorder with delusions |
| F15.251 | Other stimulant dependence with stimulant-induced psychotic disorder with hallucinations |
| F15.259 | Other stimulant dependence with stimulant-induced psychotic disorder, unspecified |
| F15.28 | Other stimulant dependence with other stimulant-induced disorder |
| F15.280 | Other stimulant dependence with stimulant-induced anxiety disorder |
| F15.281 | Other stimulant dependence with stimulant-induced sexual dysfunction |
| F15.282 | Other stimulant dependence with stimulant-induced sleep disorder |
| F15.288 | Other stimulant dependence with other stimulant-induced disorder |
| F15.29 | Other stimulant dependence with unspecified stimulant-induced disorder |
| F15.9 | Other stimulant use, unspecified |
| F15.90 | Other stimulant use, unspecified, uncomplicated |
| F15.92 | Other stimulant use, unspecified with intoxication |
| F15.920 | Other stimulant use, unspecified with intoxication, uncomplicated |
| F15.921 | Other stimulant use, unspecified with intoxication delirium |
| F15.922 | Other stimulant use, unspecified with intoxication with perceptual disturbance |
| F15.929 | Other stimulant use, unspecified with intoxication, unspecified |
| F15.93 | Other stimulant use, unspecified with withdrawal |
| F15.94 | Other stimulant use, unspecified with stimulant-induced mood disorder |
| F15.95 | Other stimulant use, unspecified with stimulant-induced psychotic disorder |
| F15.950 | Other stimulant use, unspecified with stimulant-induced psychotic disorder with delusions |
| F15.951 | Other stimulant use, unspecified with stimulant-induced psychotic disorder with hallucinations |
| F15.959 | Other stimulant use, unspecified with stimulant-induced psychotic disorder, unspecified |
| F15.98 | Other stimulant use, unspecified with other stimulant-induced disorder |
| F15.980 | Other stimulant use, unspecified with stimulant-induced anxiety disorder |
| F15.981 | Other stimulant use, unspecified with stimulant-induced sexual dysfunction |
| F15.982 | Other stimulant use, unspecified with stimulant-induced sleep disorder |
| F15.988 | Other stimulant use, unspecified with other stimulant-induced disorder |
| F15.99 | Other stimulant use, unspecified with unspecified stimulant-induced disorder |
| F16.1 | Hallucinogen abuse |
| F16.10 | Hallucinogen abuse, uncomplicated |
| F16.11 | Hallucinogen abuse, in remission |
| F16.12 | Hallucinogen abuse with intoxication |
| F16.120 | Hallucinogen abuse with intoxication, uncomplicated |
| F16.121 | Hallucinogen abuse with intoxication with delirium |
| F16.122 | Hallucinogen abuse with intoxication with perceptual disturbance |
| F16.129 | Hallucinogen abuse with intoxication, unspecified |
| F16.14 | Hallucinogen abuse with hallucinogen-induced mood disorder |
| F16.15 | Hallucinogen abuse with hallucinogen-induced psychotic disorder |
| F16.150 | Hallucinogen abuse with hallucinogen-induced psychotic disorder with delusions |
| F16.151 | Hallucinogen abuse with hallucinogen-induced psychotic disorder with hallucinations |
| F16.159 | Hallucinogen abuse with hallucinogen-induced psychotic disorder, unspecified |
| F16.18 | Hallucinogen abuse with other hallucinogen-induced disorder |
| F16.180 | Hallucinogen abuse with hallucinogen-induced anxiety disorder |
| F16.183 | Hallucinogen abuse with hallucinogen persisting perception disorder (flashbacks) |
| F16.188 | Hallucinogen abuse with other hallucinogen-induced disorder |
| F16.19 | Hallucinogen abuse with unspecified hallucinogen-induced disorder |
| F16.2 | Hallucinogen dependence |
| F16.20 | Hallucinogen dependence, uncomplicated |
| F16.21 | Hallucinogen dependence, in remission |
| F16.22 | Hallucinogen dependence with intoxication |
| F16.220 | Hallucinogen dependence with intoxication, uncomplicated |
| F16.221 | Hallucinogen dependence with intoxication with delirium |
| F16.229 | Hallucinogen dependence with intoxication, unspecified |
| F16.24 | Hallucinogen dependence with hallucinogen-induced mood disorder |
| F16.25 | Hallucinogen dependence with hallucinogen-induced psychotic disorder |
| F16.250 | Hallucinogen dependence with hallucinogen-induced psychotic disorder with delusions |
| F16.251 | Hallucinogen dependence with hallucinogen-induced psychotic disorder with hallucinations |
| F16.259 | Hallucinogen dependence with hallucinogen-induced psychotic disorder, unspecified |
| F16.28 | Hallucinogen dependence with other hallucinogen-induced disorder |
| F16.280 | Hallucinogen dependence with hallucinogen-induced anxiety disorder |
| F16.283 | Hallucinogen dependence with hallucinogen persisting perception disorder (flashbacks) |
| F16.288 | Hallucinogen dependence with other hallucinogen-induced disorder |
| F16.29 | Hallucinogen dependence with unspecified hallucinogen-induced disorder |
| F16.9 | Hallucinogen use, unspecified |
| F16.90 | Hallucinogen use, unspecified, uncomplicated |
| F16.92 | Hallucinogen use, unspecified with intoxication |
| F16.920 | Hallucinogen use, unspecified with intoxication, uncomplicated |
| F16.921 | Hallucinogen use, unspecified with intoxication with delirium |
| F16.929 | Hallucinogen use, unspecified with intoxication, unspecified |
| F16.94 | Hallucinogen use, unspecified with hallucinogen-induced mood disorder |
| F16.95 | Hallucinogen use, unspecified with hallucinogen-induced psychotic disorder |
| F16.950 | Hallucinogen use, unspecified with hallucinogen-induced psychotic disorder with delusions |
| F16.951 | Hallucinogen use, unspecified with hallucinogen-induced psychotic disorder with hallucinations |
| F16.959 | Hallucinogen use, unspecified with hallucinogen-induced psychotic disorder, unspecified |
| F16.98 | Hallucinogen use, unspecified with other specified hallucinogen-induced disorder |
| F16.980 | Hallucinogen use, unspecified with hallucinogen-induced anxiety disorder |
| F16.983 | Hallucinogen use, unspecified with hallucinogen persisting perception disorder (flashbacks) |
| F16.988 | Hallucinogen use, unspecified with other hallucinogen-induced disorder |
| F16.99 | Hallucinogen use, unspecified with unspecified hallucinogen-induced disorder |
| F18.1 | Inhalant abuse |
| F18.10 | Inhalant abuse, uncomplicated |
| F18.11 | Inhalant abuse, in remission |
| F18.12 | Inhalant abuse with intoxication |
| F18.120 | Inhalant abuse with intoxication, uncomplicated |
| F18.121 | Inhalant abuse with intoxication delirium |
| F18.129 | Inhalant abuse with intoxication, unspecified |
| F18.14 | Inhalant abuse with inhalant-induced mood disorder |
| F18.15 | Inhalant abuse with inhalant-induced psychotic disorder |
| F18.150 | Inhalant abuse with inhalant-induced psychotic disorder with delusions |
| F18.151 | Inhalant abuse with inhalant-induced psychotic disorder with hallucinations |
| F18.159 | Inhalant abuse with inhalant-induced psychotic disorder, unspecified |
| F18.17 | Inhalant abuse with inhalant-induced dementia |
| F18.18 | Inhalant abuse with other inhalant-induced disorders |
| F18.180 | Inhalant abuse with inhalant-induced anxiety disorder |
| F18.188 | Inhalant abuse with other inhalant-induced disorder |
| F18.19 | Inhalant abuse with unspecified inhalant-induced disorder |
| F18.2 | Inhalant dependence |
| F18.20 | Inhalant dependence, uncomplicated |
| F18.21 | Inhalant dependence, in remission |
| F18.22 | Inhalant dependence with intoxication |
| F18.220 | Inhalant dependence with intoxication, uncomplicated |
| F18.221 | Inhalant dependence with intoxication delirium |
| F18.229 | Inhalant dependence with intoxication, unspecified |
| F18.24 | Inhalant dependence with inhalant-induced mood disorder |
| F18.25 | Inhalant dependence with inhalant-induced psychotic disorder |
| F18.250 | Inhalant dependence with inhalant-induced psychotic disorder with delusions |
| F18.251 | Inhalant dependence with inhalant-induced psychotic disorder with hallucinations |
| F18.259 | Inhalant dependence with inhalant-induced psychotic disorder, unspecified |
| F18.27 | Inhalant dependence with inhalant-induced dementia |
| F18.28 | Inhalant dependence with other inhalant-induced disorders |
| F18.280 | Inhalant dependence with inhalant-induced anxiety disorder |
| F18.288 | Inhalant dependence with other inhalant-induced disorder |
| F18.29 | Inhalant dependence with unspecified inhalant-induced disorder |
| F18.9 | Inhalant use, unspecified |
| F18.90 | Inhalant use, unspecified, uncomplicated |
| F18.92 | Inhalant use, unspecified with intoxication |
| F18.920 | Inhalant use, unspecified with intoxication, uncomplicated |
| F18.921 | Inhalant use, unspecified with intoxication with delirium |
| F18.929 | Inhalant use, unspecified with intoxication, unspecified |
| F18.94 | Inhalant use, unspecified with inhalant-induced mood disorder |
| F18.95 | Inhalant use, unspecified with inhalant-induced psychotic disorder |
| F18.950 | Inhalant use, unspecified with inhalant-induced psychotic disorder with delusions |
| F18.951 | Inhalant use, unspecified with inhalant-induced psychotic disorder with hallucinations |
| F18.959 | Inhalant use, unspecified with inhalant-induced psychotic disorder, unspecified |
| F18.97 | Inhalant use, unspecified with inhalant-induced persisting dementia |
| F18.98 | Inhalant use, unspecified with other inhalant-induced disorders |
| F18.980 | Inhalant use, unspecified with inhalant-induced anxiety disorder |
| F18.988 | Inhalant use, unspecified with other inhalant-induced disorder |
| F18.99 | Inhalant use, unspecified with unspecified inhalant-induced disorder |
| F19.1 | Other psychoactive substance abuse |
| F19.10 | Other psychoactive substance abuse, uncomplicated |
| F19.11 | Other psychoactive substance abuse, in remission |
| F19.12 | Other psychoactive substance abuse with intoxication |
| F19.120 | Other psychoactive substance abuse with intoxication, uncomplicated |
| F19.121 | Other psychoactive substance abuse with intoxication delirium |
| F19.122 | Other psychoactive substance abuse with intoxication with perceptual disturbances |
| F19.129 | Other psychoactive substance abuse with intoxication, unspecified |
| F19.13 | Other psychoactive substance abuse with withdrawal |
| F19.130 | Other psychoactive substance abuse with withdrawal, uncomplicated |
| F19.131 | Other psychoactive substance abuse with withdrawal delirium |
| F19.132 | Other psychoactive substance abuse with withdrawal with perceptual disturbance |
| F19.139 | Other psychoactive substance abuse with withdrawal, unspecified |
| F19.14 | Other psychoactive substance abuse with psychoactive substance-induced mood disorder |
| F19.15 | Other psychoactive substance abuse with psychoactive substance-induced psychotic disorder |
| F19.150 | Other psychoactive substance abuse with psychoactive substance-induced psychotic disorder with delusions |
| F19.151 | Other psychoactive substance abuse with psychoactive substance-induced psychotic disorder with hallucinations |
| F19.159 | Other psychoactive substance abuse with psychoactive substance-induced psychotic disorder, unspecified |
| F19.16 | Other psychoactive substance abuse with psychoactive substance-induced persisting amnestic disorder |
| F19.17 | Other psychoactive substance abuse with psychoactive substance-induced persisting dementia |
| F19.18 | Other psychoactive substance abuse with other psychoactive substance-induced disorders |
| F19.180 | Other psychoactive substance abuse with psychoactive substance-induced anxiety disorder |
| F19.181 | Other psychoactive substance abuse with psychoactive substance-induced sexual dysfunction |
| F19.182 | Other psychoactive substance abuse with psychoactive substance-induced sleep disorder |
| F19.188 | Other psychoactive substance abuse with other psychoactive substance-induced disorder |
| F19.19 | Other psychoactive substance abuse with unspecified psychoactive substance-induced disorder |
| F19.2 | Other psychoactive substance dependence |
| F19.20 | Other psychoactive substance dependence, uncomplicated |
| F19.21 | Other psychoactive substance dependence, in remission |
| F19.22 | Other psychoactive substance dependence with intoxication |
| F19.220 | Other psychoactive substance dependence with intoxication, uncomplicated |
| F19.221 | Other psychoactive substance dependence with intoxication delirium |
| F19.222 | Other psychoactive substance dependence with intoxication with perceptual disturbance |
| F19.229 | Other psychoactive substance dependence with intoxication, unspecified |
| F19.23 | Other psychoactive substance dependence with withdrawal |
| F19.230 | Other psychoactive substance dependence with withdrawal, uncomplicated |
| F19.231 | Other psychoactive substance dependence with withdrawal delirium |
| F19.232 | Other psychoactive substance dependence with withdrawal with perceptual disturbance |
| F19.239 | Other psychoactive substance dependence with withdrawal, unspecified |
| F19.24 | Other psychoactive substance dependence with psychoactive substance-induced mood disorder |
| F19.25 | Other psychoactive substance dependence with psychoactive substance-induced psychotic disorder |
| F19.250 | Other psychoactive substance dependence with psychoactive substance-induced psychotic disorder with delusions |
| F19.251 | Other psychoactive substance dependence with psychoactive substance-induced psychotic disorder with hallucinations |
| F19.259 | Other psychoactive substance dependence with psychoactive substance-induced psychotic disorder, unspecified |
| F19.26 | Other psychoactive substance dependence with psychoactive substance-induced persisting amnestic disorder |
| F19.27 | Other psychoactive substance dependence with psychoactive substance-induced persisting dementia |
| F19.28 | Other psychoactive substance dependence with other psychoactive substance-induced disorders |
| F19.280 | Other psychoactive substance dependence with psychoactive substance-induced anxiety disorder |
| F19.281 | Other psychoactive substance dependence with psychoactive substance-induced sexual dysfunction |
| F19.282 | Other psychoactive substance dependence with psychoactive substance-induced sleep disorder |
| F19.288 | Other psychoactive substance dependence with other psychoactive substance-induced disorder |
| F19.29 | Other psychoactive substance dependence with unspecified psychoactive substance-induced disorder |
| F19.9 | Other psychoactive substance use, unspecified |
| F19.90 | Other psychoactive substance use, unspecified, uncomplicated |
| F19.92 | Other psychoactive substance use, unspecified with intoxication |
| F19.920 | Other psychoactive substance use, unspecified with intoxication, uncomplicated |
| F19.921 | Other psychoactive substance use, unspecified with intoxication with delirium |
| F19.922 | Other psychoactive substance use, unspecified with intoxication with perceptual disturbance |
| F19.929 | Other psychoactive substance use, unspecified with intoxication, unspecified |
| F19.93 | Other psychoactive substance use, unspecified with withdrawal |
| F19.930 | Other psychoactive substance use, unspecified with withdrawal, uncomplicated |
| F19.931 | Other psychoactive substance use, unspecified with withdrawal delirium |
| F19.932 | Other psychoactive substance use, unspecified with withdrawal with perceptual disturbance |
| F19.939 | Other psychoactive substance use, unspecified with withdrawal, unspecified |
| F19.94 | Other psychoactive substance use, unspecified with psychoactive substance-induced mood disorder |
| F19.95 | Other psychoactive substance use, unspecified with psychoactive substance-induced psychotic disorder |
| F19.950 | Other psychoactive substance use, unspecified with psychoactive substance-induced psychotic disorder with delusions |
| F19.951 | Other psychoactive substance use, unspecified with psychoactive substance-induced psychotic disorder with hallucinations |
| F19.959 | Other psychoactive substance use, unspecified with psychoactive substance-induced psychotic disorder, unspecified |
| F19.96 | Other psychoactive substance use, unspecified with psychoactive substance-induced persisting amnestic disorder |
| F19.97 | Other psychoactive substance use, unspecified with psychoactive substance-induced persisting dementia |
| F19.98 | Other psychoactive substance use, unspecified with other psychoactive substance-induced disorders |
| F19.980 | Other psychoactive substance use, unspecified with psychoactive substance-induced anxiety disorder |
| F19.981 | Other psychoactive substance use, unspecified with psychoactive substance-induced sexual dysfunction |
| F19.982 | Other psychoactive substance use, unspecified with psychoactive substance-induced sleep disorder |
| F19.988 | Other psychoactive substance use, unspecified with other psychoactive substance-induced disorder |
| F19.99 | Other psychoactive substance use, unspecified with unspecified psychoactive substance-induced disorder |
| F55.0 | Abuse of antacids |
| F55.1 | Abuse of herbal or folk remedies |
| F55.2 | Abuse of laxatives |
| F55.3 | Abuse of steroids or hormones |
| F55.4 | Abuse of vitamins |
| F55.8 | Abuse of other non-psychoactive substances |
| G58.0 | Intercostal neuropathy |
| G58.7 | Mononeuritis multiplex |
| G58.8 | Other specified mononeuropathies |
| G58.9 | Mononeuropathy, unspecified |
| G60.0 | Hereditary motor and sensory neuropathy |
| G60.1 | Refsum's disease |
| G60.2 | Neuropathy in association with hereditary ataxia |
| G60.3 | Idiopathic progressive neuropathy |
| G60.8 | Other hereditary and idiopathic neuropathies |
| G60.9 | Hereditary and idiopathic neuropathy, unspecified |
| G61.0 | Guillain-Barre syndrome |
| G61.1 | Serum neuropathy |
| G61.8 | Other inflammatory polyneuropathies |
| G61.81 | Chronic inflammatory demyelinating polyneuritis |
| G61.82 | Multifocal motor neuropathy |
| G61.89 | Other inflammatory polyneuropathies |
| G61.9 | Inflammatory polyneuropathy, unspecified |
| G62.0 | Drug-induced polyneuropathy |
| G62.1 | Alcoholic polyneuropathy |
| G62.2 | Polyneuropathy due to other toxic agents |
| G62.8 | Other specified polyneuropathies |
| G62.81 | Critical illness polyneuropathy |
| G62.82 | Radiation-induced polyneuropathy |
| G62.89 | Other specified polyneuropathies |
| G62.9 | Polyneuropathy, unspecified |
| G89.29 | Other chronic pain |
| G89.4 | Chronic pain syndrome |
| G99.0 | Autonomic neuropathy in diseases classified elsewhere |
| G99.2 | Myelopathy in diseases classified elsewhere |
| G99.8 | Other specified disorders of nervous system in diseases classified elsewhere |
| H35.06 | Retinal vasculitis |
| H35.061 | Retinal vasculitis, right eye |
| H35.062 | Retinal vasculitis, left eye |
| H35.063 | Retinal vasculitis, bilateral |
| H35.069 | Retinal vasculitis, unspecified eye |
| I12.0 | Hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease |
| I12.9 | Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease |
| I13.0 | Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease |
| I13.1 | Hypertensive heart and chronic kidney disease without heart failure |
| I13.10 | Hypertensive heart and chronic kidney disease without heart failure, with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease |
| I13.11 | Hypertensive heart and chronic kidney disease without heart failure, with stage 5 chronic kidney disease, or end stage renal disease |
| I13.2 | Hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease |
| I67.7 | Cerebral arteritis, not elsewhere classified |
| I68.2 | Cerebral arteritis in other diseases classified elsewhere |
| I77.0 | Arteriovenous fistula, acquired |
| I77.1 | Stricture of artery |
| I77.2 | Rupture of artery |
| I77.3 | Arterial fibromuscular dysplasia |
| I77.4 | Celiac artery compression syndrome |
| I77.5 | Necrosis of artery |
| I77.6 | Arteritis, unspecified |
| I77.7 | Other arterial dissection |
| I77.70 | Dissection of unspecified artery |
| I77.71 | Dissection of carotid artery |
| I77.72 | Dissection of iliac artery |
| I77.73 | Dissection of renal artery |
| I77.74 | Dissection of vertebral artery |
| I77.75 | Dissection of other precerebral arteries |
| I77.76 | Dissection of artery of upper extremity |
| I77.77 | Dissection of artery of lower extremity |
| I77.79 | Dissection of other specified artery |
| I77.8 | Other specified disorders of arteries and arterioles |
| I77.81 | Aortic ectasia |
| I77.810 | Thoracic aortic ectasia |
| I77.811 | Abdominal aortic ectasia |
| I77.812 | Thoracoabdominal aortic ectasia |
| I77.819 | Aortic ectasia, unspecified site |
| I77.89 | Other specified disorders of arteries and arterioles |
| I77.9 | Disorder of arteries and arterioles, unspecified |
| K65.0 | Generalized (acute) peritonitis |
| K65.1 | Peritoneal abscess |
| K65.2 | Spontaneous bacterial peritonitis |
| K65.3 | Choleperitonitis |
| K65.4 | Sclerosing mesenteritis |
| K65.8 | Other peritonitis |
| K65.9 | Peritonitis, unspecified |
| K70.0 | Alcoholic fatty liver |
| K70.1 | Alcoholic hepatitis |
| K70.10 | Alcoholic hepatitis without ascites |
| K70.11 | Alcoholic hepatitis with ascites |
| K70.2 | Alcoholic fibrosis and sclerosis of liver |
| K70.3 | Alcoholic cirrhosis of liver |
| K70.30 | Alcoholic cirrhosis of liver without ascites |
| K70.31 | Alcoholic cirrhosis of liver with ascites |
| K70.4 | Alcoholic hepatic failure |
| K70.40 | Alcoholic hepatic failure without coma |
| K70.41 | Alcoholic hepatic failure with coma |
| K70.9 | Alcoholic liver disease, unspecified |
| K71.0 | Toxic liver disease with cholestasis |
| K71.1 | Toxic liver disease with hepatic necrosis |
| K71.10 | Toxic liver disease with hepatic necrosis, without coma |
| K71.11 | Toxic liver disease with hepatic necrosis, with coma |
| K71.2 | Toxic liver disease with acute hepatitis |
| K71.3 | Toxic liver disease with chronic persistent hepatitis |
| K71.4 | Toxic liver disease with chronic lobular hepatitis |
| K71.5 | Toxic liver disease with chronic active hepatitis |
| K71.50 | Toxic liver disease with chronic active hepatitis without ascites |
| K71.51 | Toxic liver disease with chronic active hepatitis with ascites |
| K71.6 | Toxic liver disease with hepatitis, not elsewhere classified |
| K71.7 | Toxic liver disease with fibrosis and cirrhosis of liver |
| K71.8 | Toxic liver disease with other disorders of liver |
| K71.9 | Toxic liver disease, unspecified |
| K72.0 | Acute and subacute hepatic failure |
| K72.00 | Acute and subacute hepatic failure without coma |
| K72.01 | Acute and subacute hepatic failure with coma |
| K72.1 | Chronic hepatic failure |
| K72.10 | Chronic hepatic failure without coma |
| K72.11 | Chronic hepatic failure with coma |
| K72.9 | Hepatic failure, unspecified |
| K72.90 | Hepatic failure, unspecified without coma |
| K72.91 | Hepatic failure, unspecified with coma |
| K73.0 | Chronic persistent hepatitis, not elsewhere classified |
| K73.1 | Chronic lobular hepatitis, not elsewhere classified |
| K73.2 | Chronic active hepatitis, not elsewhere classified |
| K73.8 | Other chronic hepatitis, not elsewhere classified |
| K73.9 | Chronic hepatitis, unspecified |
| K74.0 | Hepatic fibrosis |
| K74.00 | Hepatic fibrosis, unspecified |
| K74.01 | Hepatic fibrosis, early fibrosis |
| K74.02 | Hepatic fibrosis, advanced fibrosis |
| K74.1 | Hepatic sclerosis |
| K74.2 | Hepatic fibrosis with hepatic sclerosis |
| K74.3 | Primary biliary cirrhosis |
| K74.4 | Secondary biliary cirrhosis |
| K74.5 | Biliary cirrhosis, unspecified |
| K74.6 | Other and unspecified cirrhosis of liver |
| K74.60 | Unspecified cirrhosis of liver |
| K74.69 | Other cirrhosis of liver |
| K75.0 | Abscess of liver |
| K75.1 | Phlebitis of portal vein |
| K75.2 | Nonspecific reactive hepatitis |
| K75.3 | Granulomatous hepatitis, not elsewhere classified |
| K75.4 | Autoimmune hepatitis |
| K75.8 | Other specified inflammatory liver diseases |
| K75.81 | Nonalcoholic steatohepatitis (NASH) |
| K75.89 | Other specified inflammatory liver diseases |
| K75.9 | Inflammatory liver disease, unspecified |
| K76.0 | Fatty (change of) liver, not elsewhere classified |
| K76.1 | Chronic passive congestion of liver |
| K76.2 | Central hemorrhagic necrosis of liver |
| K76.3 | Infarction of liver |
| K76.4 | Peliosis hepatis |
| K76.5 | Hepatic veno-occlusive disease |
| K76.6 | Portal hypertension |
| K76.7 | Hepatorenal syndrome |
| K76.8 | Other specified diseases of liver |
| K76.81 | Hepatopulmonary syndrome |
| K76.89 | Other specified diseases of liver |
| K76.9 | Liver disease, unspecified |
| L93.0 | Discoid lupus erythematosus |
| L93.1 | Subacute cutaneous lupus erythematosus |
| L93.2 | Other local lupus erythematosus |
| L95.0 | Livedoid vasculitis |
| L95.1 | Erythema elevatum diutinum |
| L95.8 | Other vasculitis limited to the skin |
| L95.9 | Vasculitis limited to the skin, unspecified |
| M05.2 | Rheumatoid vasculitis with rheumatoid arthritis |
| M05.20 | Rheumatoid vasculitis with rheumatoid arthritis of unspecified site |
| M05.21 | Rheumatoid vasculitis with rheumatoid arthritis of shoulder |
| M05.211 | Rheumatoid vasculitis with rheumatoid arthritis of right shoulder |
| M05.212 | Rheumatoid vasculitis with rheumatoid arthritis of left shoulder |
| M05.219 | Rheumatoid vasculitis with rheumatoid arthritis of unspecified shoulder |
| M05.22 | Rheumatoid vasculitis with rheumatoid arthritis of elbow |
| M05.221 | Rheumatoid vasculitis with rheumatoid arthritis of right elbow |
| M05.222 | Rheumatoid vasculitis with rheumatoid arthritis of left elbow |
| M05.229 | Rheumatoid vasculitis with rheumatoid arthritis of unspecified elbow |
| M05.23 | Rheumatoid vasculitis with rheumatoid arthritis of wrist |
| M05.231 | Rheumatoid vasculitis with rheumatoid arthritis of right wrist |
| M05.232 | Rheumatoid vasculitis with rheumatoid arthritis of left wrist |
| M05.239 | Rheumatoid vasculitis with rheumatoid arthritis of unspecified wrist |
| M05.24 | Rheumatoid vasculitis with rheumatoid arthritis of hand |
| M05.241 | Rheumatoid vasculitis with rheumatoid arthritis of right hand |
| M05.242 | Rheumatoid vasculitis with rheumatoid arthritis of left hand |
| M05.249 | Rheumatoid vasculitis with rheumatoid arthritis of unspecified hand |
| M05.25 | Rheumatoid vasculitis with rheumatoid arthritis of hip |
| M05.251 | Rheumatoid vasculitis with rheumatoid arthritis of right hip |
| M05.252 | Rheumatoid vasculitis with rheumatoid arthritis of left hip |
| M05.259 | Rheumatoid vasculitis with rheumatoid arthritis of unspecified hip |
| M05.26 | Rheumatoid vasculitis with rheumatoid arthritis of knee |
| M05.261 | Rheumatoid vasculitis with rheumatoid arthritis of right knee |
| M05.262 | Rheumatoid vasculitis with rheumatoid arthritis of left knee |
| M05.269 | Rheumatoid vasculitis with rheumatoid arthritis of unspecified knee |
| M05.27 | Rheumatoid vasculitis with rheumatoid arthritis of ankle and foot |
| M05.271 | Rheumatoid vasculitis with rheumatoid arthritis of right ankle and foot |
| M05.272 | Rheumatoid vasculitis with rheumatoid arthritis of left ankle and foot |
| M05.279 | Rheumatoid vasculitis with rheumatoid arthritis of unspecified ankle and foot |
| M05.29 | Rheumatoid vasculitis with rheumatoid arthritis of multiple sites |
| M05.50 | Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified site |
| M25.5 | Pain in joint |
| M30.0 | Polyarteritis nodosa |
| M30.1 | Polyarteritis with lung involvement [Churg-Strauss] |
| M30.2 | Juvenile polyarteritis |
| M30.3 | Mucocutaneous lymph node syndrome [Kawasaki] |
| M30.8 | Other conditions related to polyarteritis nodosa |
| M31.0 | Hypersensitivity angiitis |
| M31.1 | Thrombotic microangiopathy |
| M31.2 | Lethal midline granuloma |
| M31.3 | Wegener's granulomatosis |
| M31.30 | Wegener's granulomatosis without renal involvement |
| M31.31 | Wegener's granulomatosis with renal involvement |
| M31.4 | Aortic arch syndrome [Takayasu] |
| M31.5 | Giant cell arteritis with polymyalgia rheumatica |
| M31.6 | Other giant cell arteritis |
| M31.7 | Microscopic polyangiitis |
| M31.8 | Other specified necrotizing vasculopathies |
| M31.9 | Necrotizing vasculopathy, unspecified |
| M32.0 | Drug-induced systemic lupus erythematosus |
| M32.1 | Systemic lupus erythematosus with organ or system involvement |
| M32.10 | Systemic lupus erythematosus, organ or system involvement unspecified |
| M32.11 | Endocarditis in systemic lupus erythematosus |
| M32.12 | Pericarditis in systemic lupus erythematosus |
| M32.13 | Lung involvement in systemic lupus erythematosus |
| M32.14 | Glomerular disease in systemic lupus erythematosus |
| M32.15 | Tubulo-interstitial nephropathy in systemic lupus erythematosus |
| M32.19 | Other organ or system involvement in systemic lupus erythematosus |
| M32.8 | Other forms of systemic lupus erythematosus |
| M32.9 | Systemic lupus erythematosus, unspecified |
| M34.83 | Systemic sclerosis with polyneuropathy |
| N00.0 | Acute nephritic syndrome with minor glomerular abnormality |
| N00.1 | Acute nephritic syndrome with focal and segmental glomerular lesions |
| N00.2 | Acute nephritic syndrome with diffuse membranous glomerulonephritis |
| N00.3 | Acute nephritic syndrome with diffuse mesangial proliferative glomerulonephritis |
| N00.4 | Acute nephritic syndrome with diffuse endocapillary proliferative glomerulonephritis |
| N00.5 | Acute nephritic syndrome with diffuse mesangiocapillary glomerulonephritis |
| N00.6 | Acute nephritic syndrome with dense deposit disease |
| N00.7 | Acute nephritic syndrome with diffuse crescentic glomerulonephritis |
| N00.8 | Acute nephritic syndrome with other morphologic changes |
| N00.9 | Acute nephritic syndrome with unspecified morphologic changes |
| N00.A | Acute nephritic syndrome with C3 glomerulonephritis |
| N02.0 | Recurrent and persistent hematuria with minor glomerular abnormality |
| N02.1 | Recurrent and persistent hematuria with focal and segmental glomerular lesions |
| N02.2 | Recurrent and persistent hematuria with diffuse membranous glomerulonephritis |
| N02.3 | Recurrent and persistent hematuria with diffuse mesangial proliferative glomerulonephritis |
| N02.4 | Recurrent and persistent hematuria with diffuse endocapillary proliferative glomerulonephritis |
| N02.5 | Recurrent and persistent hematuria with diffuse mesangiocapillary glomerulonephritis |
| N02.6 | Recurrent and persistent hematuria with dense deposit disease |
| N02.7 | Recurrent and persistent hematuria with diffuse crescentic glomerulonephritis |
| N02.8 | Recurrent and persistent hematuria with other morphologic changes |
| N02.9 | Recurrent and persistent hematuria with unspecified morphologic changes |
| N02.A | Recurrent and persistent hematuria with C3 glomerulonephritis |
| N03.0 | Chronic nephritic syndrome with minor glomerular abnormality |
| N03.1 | Chronic nephritic syndrome with focal and segmental glomerular lesions |
| N03.2 | Chronic nephritic syndrome with diffuse membranous glomerulonephritis |
| N03.3 | Chronic nephritic syndrome with diffuse mesangial proliferative glomerulonephritis |
| N03.4 | Chronic nephritic syndrome with diffuse endocapillary proliferative glomerulonephritis |
| N03.5 | Chronic nephritic syndrome with diffuse mesangiocapillary glomerulonephritis |
| N03.6 | Chronic nephritic syndrome with dense deposit disease |
| N03.7 | Chronic nephritic syndrome with diffuse crescentic glomerulonephritis |
| N03.8 | Chronic nephritic syndrome with other morphologic changes |
| N03.9 | Chronic nephritic syndrome with unspecified morphologic changes |
| N03.A | Chronic nephritic syndrome with C3 glomerulonephritis |
| N04.0 | Nephrotic syndrome with minor glomerular abnormality |
| N04.1 | Nephrotic syndrome with focal and segmental glomerular lesions |
| N04.2 | Nephrotic syndrome with diffuse membranous glomerulonephritis |
| N04.3 | Nephrotic syndrome with diffuse mesangial proliferative glomerulonephritis |
| N04.4 | Nephrotic syndrome with diffuse endocapillary proliferative glomerulonephritis |
| N04.5 | Nephrotic syndrome with diffuse mesangiocapillary glomerulonephritis |
| N04.6 | Nephrotic syndrome with dense deposit disease |
| N04.7 | Nephrotic syndrome with diffuse crescentic glomerulonephritis |
| N04.8 | Nephrotic syndrome with other morphologic changes |
| N04.9 | Nephrotic syndrome with unspecified morphologic changes |
| N04.A | Nephrotic syndrome with C3 glomerulonephritis |
| N05.0 | Unspecified nephritic syndrome with minor glomerular abnormality |
| N05.1 | Unspecified nephritic syndrome with focal and segmental glomerular lesions |
| N05.2 | Unspecified nephritic syndrome with diffuse membranous glomerulonephritis |
| N05.3 | Unspecified nephritic syndrome with diffuse mesangial proliferative glomerulonephritis |
| N05.4 | Unspecified nephritic syndrome with diffuse endocapillary proliferative glomerulonephritis |
| N05.5 | Unspecified nephritic syndrome with diffuse mesangiocapillary glomerulonephritis |
| N05.6 | Unspecified nephritic syndrome with dense deposit disease |
| N05.7 | Unspecified nephritic syndrome with diffuse crescentic glomerulonephritis |
| N05.8 | Unspecified nephritic syndrome with other morphologic changes |
| N05.9 | Unspecified nephritic syndrome with unspecified morphologic changes |
| N05.A | Unspecified nephritic syndrome with C3 glomerulonephritis |
| N06.0 | Isolated proteinuria with minor glomerular abnormality |
| N06.1 | Isolated proteinuria with focal and segmental glomerular lesions |
| N06.2 | Isolated proteinuria with diffuse membranous glomerulonephritis |
| N06.3 | Isolated proteinuria with diffuse mesangial proliferative glomerulonephritis |
| N06.4 | Isolated proteinuria with diffuse endocapillary proliferative glomerulonephritis |
| N06.5 | Isolated proteinuria with diffuse mesangiocapillary glomerulonephritis |
| N06.6 | Isolated proteinuria with dense deposit disease |
| N06.7 | Isolated proteinuria with diffuse crescentic glomerulonephritis |
| N06.8 | Isolated proteinuria with other morphologic lesion |
| N06.9 | Isolated proteinuria with unspecified morphologic lesion |
| N06.A | Isolated proteinuria with C3 glomerulonephritis |
| N13.0 | Hydronephrosis with ureteropelvic junction obstruction |
| N13.1 | Hydronephrosis with ureteral stricture, not elsewhere classified |
| N13.2 | Hydronephrosis with renal and ureteral calculous obstruction |
| N13.3 | Other and unspecified hydronephrosis |
| N13.30 | Unspecified hydronephrosis |
| N13.39 | Other hydronephrosis |
| N13.4 | Hydroureter |
| N13.5 | Crossing vessel and stricture of ureter without hydronephrosis |
| N13.6 | Pyonephrosis |
| N13.7 | Vesicoureteral-reflux |
| N13.70 | Vesicoureteral-reflux, unspecified |
| N13.71 | Vesicoureteral-reflux without reflux nephropathy |
| N13.72 | Vesicoureteral-reflux with reflux nephropathy without hydroureter |
| N13.721 | Vesicoureteral-reflux with reflux nephropathy without hydroureter, unilateral |
| N13.722 | Vesicoureteral-reflux with reflux nephropathy without hydroureter, bilateral |
| N13.729 | Vesicoureteral-reflux with reflux nephropathy without hydroureter, unspecified |
| N13.73 | Vesicoureteral-reflux with reflux nephropathy with hydroureter |
| N13.731 | Vesicoureteral-reflux with reflux nephropathy with hydroureter, unilateral |
| N13.732 | Vesicoureteral-reflux with reflux nephropathy with hydroureter, bilateral |
| N13.739 | Vesicoureteral-reflux with reflux nephropathy with hydroureter, unspecified |
| N13.8 | Other obstructive and reflux uropathy |
| N13.9 | Obstructive and reflux uropathy, unspecified |
| N18.1 | Chronic kidney disease, stage 1 |
| N18.2 | Chronic kidney disease, stage 2 (mild) |
| N18.3 | Chronic kidney disease, stage 3 (moderate) |
| N18.30 | Chronic kidney disease, stage 3 unspecified |
| N18.31 | Chronic kidney disease, stage 3a |
| N18.32 | Chronic kidney disease, stage 3b |
| N18.4 | Chronic kidney disease, stage 4 (severe) |
| N18.5 | Chronic kidney disease, stage 5 |
| N18.6 | End stage renal disease |
| N18.9 | Chronic kidney disease, unspecified |
| N26.1 | Atrophy of kidney (terminal) |
| N26.2 | Page kidney |
| N26.9 | Renal sclerosis, unspecified |
| N98.3 | Complications of attempted introduction of embryo in embryo transfer |
| O09.0 | Supervision of pregnancy with history of infertility |
| O09.00 | Supervision of pregnancy with history of infertility, unspecified trimester |
| O09.01 | Supervision of pregnancy with history of infertility, first trimester |
| O09.02 | Supervision of pregnancy with history of infertility, second trimester |
| O09.03 | Supervision of pregnancy with history of infertility, third trimester |
| O09.1 | Supervision of pregnancy with history of ectopic pregnancy |
| O09.10 | Supervision of pregnancy with history of ectopic pregnancy, unspecified trimester |
| O09.11 | Supervision of pregnancy with history of ectopic pregnancy, first trimester |
| O09.12 | Supervision of pregnancy with history of ectopic pregnancy, second trimester |
| O09.13 | Supervision of pregnancy with history of ectopic pregnancy, third trimester |
| O09.2 | Supervision of pregnancy with other poor reproductive or obstetric history |
| O09.21 | Supervision of pregnancy with history of pre-term labor |
| O09.211 | Supervision of pregnancy with history of pre-term labor, first trimester |
| O09.212 | Supervision of pregnancy with history of pre-term labor, second trimester |
| O09.213 | Supervision of pregnancy with history of pre-term labor, third trimester |
| O09.219 | Supervision of pregnancy with history of pre-term labor, unspecified trimester |
| O09.29 | Supervision of pregnancy with other poor reproductive or obstetric history |
| O09.291 | Supervision of pregnancy with other poor reproductive or obstetric history, first trimester |
| O09.292 | Supervision of pregnancy with other poor reproductive or obstetric history, second trimester |
| O09.293 | Supervision of pregnancy with other poor reproductive or obstetric history, third trimester |
| O09.299 | Supervision of pregnancy with other poor reproductive or obstetric history, unspecified trimester |
| O09.3 | Supervision of pregnancy with insufficient antenatal care |
| O09.30 | Supervision of pregnancy with insufficient antenatal care, unspecified trimester |
| O09.31 | Supervision of pregnancy with insufficient antenatal care, first trimester |
| O09.32 | Supervision of pregnancy with insufficient antenatal care, second trimester |
| O09.33 | Supervision of pregnancy with insufficient antenatal care, third trimester |
| O09.4 | Supervision of pregnancy with grand multiparity |
| O09.40 | Supervision of pregnancy with grand multiparity, unspecified trimester |
| O09.41 | Supervision of pregnancy with grand multiparity, first trimester |
| O09.42 | Supervision of pregnancy with grand multiparity, second trimester |
| O09.43 | Supervision of pregnancy with grand multiparity, third trimester |
| O09.5 | Supervision of elderly primigravida and multigravida |
| O09.51 | Supervision of elderly primigravida |
| O09.511 | Supervision of elderly primigravida, first trimester |
| O09.512 | Supervision of elderly primigravida, second trimester |
| O09.513 | Supervision of elderly primigravida, third trimester |
| O09.519 | Supervision of elderly primigravida, unspecified trimester |
| O09.52 | Supervision of elderly multigravida |
| O09.521 | Supervision of elderly multigravida, first trimester |
| O09.522 | Supervision of elderly multigravida, second trimester |
| O09.523 | Supervision of elderly multigravida, third trimester |
| O09.529 | Supervision of elderly multigravida, unspecified trimester |
| O09.6 | Supervision of young primigravida and multigravida |
| O09.61 | Supervision of young primigravida |
| O09.611 | Supervision of young primigravida, first trimester |
| O09.612 | Supervision of young primigravida, second trimester |
| O09.613 | Supervision of young primigravida, third trimester |
| O09.619 | Supervision of young primigravida, unspecified trimester |
| O09.62 | Supervision of young multigravida |
| O09.621 | Supervision of young multigravida, first trimester |
| O09.622 | Supervision of young multigravida, second trimester |
| O09.623 | Supervision of young multigravida, third trimester |
| O09.629 | Supervision of young multigravida, unspecified trimester |
| O09.7 | Supervision of high risk pregnancy due to social problems |
| O09.70 | Supervision of high risk pregnancy due to social problems, unspecified trimester |
| O09.71 | Supervision of high risk pregnancy due to social problems, first trimester |
| O09.72 | Supervision of high risk pregnancy due to social problems, second trimester |
| O09.73 | Supervision of high risk pregnancy due to social problems, third trimester |
| O09.8 | Supervision of other high risk pregnancies |
| O09.81 | Supervision of pregnancy resulting from assisted reproductive technology |
| O09.811 | Supervision of pregnancy resulting from assisted reproductive technology, first trimester |
| O09.812 | Supervision of pregnancy resulting from assisted reproductive technology, second trimester |
| O09.813 | Supervision of pregnancy resulting from assisted reproductive technology, third trimester |
| O09.819 | Supervision of pregnancy resulting from assisted reproductive technology, unspecified trimester |
| O09.82 | Supervision of pregnancy with history of in utero procedure during previous pregnancy |
| O09.821 | Supervision of pregnancy with history of in utero procedure during previous pregnancy, first trimester |
| O09.822 | Supervision of pregnancy with history of in utero procedure during previous pregnancy, second trimester |
| O09.823 | Supervision of pregnancy with history of in utero procedure during previous pregnancy, third trimester |
| O09.829 | Supervision of pregnancy with history of in utero procedure during previous pregnancy, unspecified trimester |
| O09.89 | Supervision of other high risk pregnancies |
| O09.891 | Supervision of other high risk pregnancies, first trimester |
| O09.892 | Supervision of other high risk pregnancies, second trimester |
| O09.893 | Supervision of other high risk pregnancies, third trimester |
| O09.899 | Supervision of other high risk pregnancies, unspecified trimester |
| O09.9 | Supervision of high risk pregnancy, unspecified |
| O09.90 | Supervision of high risk pregnancy, unspecified, unspecified trimester |
| O09.91 | Supervision of high risk pregnancy, unspecified, first trimester |
| O09.92 | Supervision of high risk pregnancy, unspecified, second trimester |
| O09.93 | Supervision of high risk pregnancy, unspecified, third trimester |
| O09.A | Supervision of pregnancy with history of molar pregnancy |
| O09.A0 | Supervision of pregnancy with history of molar pregnancy, unspecified trimester |
| O09.A1 | Supervision of pregnancy with history of molar pregnancy, first trimester |
| O09.A2 | Supervision of pregnancy with history of molar pregnancy, second trimester |
| O09.A3 | Supervision of pregnancy with history of molar pregnancy, third trimester |
| O12.0 | Gestational edema |
| O12.00 | Gestational edema, unspecified trimester |
| O12.01 | Gestational edema, first trimester |
| O12.02 | Gestational edema, second trimester |
| O12.03 | Gestational edema, third trimester |
| O12.04 | Gestational edema, complicating childbirth |
| O12.05 | Gestational edema, complicating the puerperium |
| O12.1 | Gestational proteinuria |
| O12.10 | Gestational proteinuria, unspecified trimester |
| O12.11 | Gestational proteinuria, first trimester |
| O12.12 | Gestational proteinuria, second trimester |
| O12.13 | Gestational proteinuria, third trimester |
| O12.14 | Gestational proteinuria, complicating childbirth |
| O12.15 | Gestational proteinuria, complicating the puerperium |
| O12.2 | Gestational edema with proteinuria |
| O12.20 | Gestational edema with proteinuria, unspecified trimester |
| O12.21 | Gestational edema with proteinuria, first trimester |
| O12.22 | Gestational edema with proteinuria, second trimester |
| O12.23 | Gestational edema with proteinuria, third trimester |
| O12.24 | Gestational edema with proteinuria, complicating childbirth |
| O12.25 | Gestational edema with proteinuria, complicating the puerperium |
| O26.0 | Excessive weight gain in pregnancy |
| O26.00 | Excessive weight gain in pregnancy, unspecified trimester |
| O26.01 | Excessive weight gain in pregnancy, first trimester |
| O26.02 | Excessive weight gain in pregnancy, second trimester |
| O26.03 | Excessive weight gain in pregnancy, third trimester |
| O26.1 | Low weight gain in pregnancy |
| O26.10 | Low weight gain in pregnancy, unspecified trimester |
| O26.11 | Low weight gain in pregnancy, first trimester |
| O26.12 | Low weight gain in pregnancy, second trimester |
| O26.13 | Low weight gain in pregnancy, third trimester |
| O26.2 | Pregnancy care for patient with recurrent pregnancy loss |
| O26.20 | Pregnancy care for patient with recurrent pregnancy loss, unspecified trimester |
| O26.21 | Pregnancy care for patient with recurrent pregnancy loss, first trimester |
| O26.22 | Pregnancy care for patient with recurrent pregnancy loss, second trimester |
| O26.23 | Pregnancy care for patient with recurrent pregnancy loss, third trimester |
| O26.3 | Retained intrauterine contraceptive device in pregnancy |
| O26.30 | Retained intrauterine contraceptive device in pregnancy, unspecified trimester |
| O26.31 | Retained intrauterine contraceptive device in pregnancy, first trimester |
| O26.32 | Retained intrauterine contraceptive device in pregnancy, second trimester |
| O26.33 | Retained intrauterine contraceptive device in pregnancy, third trimester |
| O26.4 | Herpes gestationis |
| O26.40 | Herpes gestationis, unspecified trimester |
| O26.41 | Herpes gestationis, first trimester |
| O26.42 | Herpes gestationis, second trimester |
| O26.43 | Herpes gestationis, third trimester |
| O26.5 | Maternal hypotension syndrome |
| O26.50 | Maternal hypotension syndrome, unspecified trimester |
| O26.51 | Maternal hypotension syndrome, first trimester |
| O26.52 | Maternal hypotension syndrome, second trimester |
| O26.53 | Maternal hypotension syndrome, third trimester |
| O26.6 | Liver and biliary tract disorders in pregnancy, childbirth and the puerperium |
| O26.61 | Liver and biliary tract disorders in pregnancy |
| O26.611 | Liver and biliary tract disorders in pregnancy, first trimester |
| O26.612 | Liver and biliary tract disorders in pregnancy, second trimester |
| O26.613 | Liver and biliary tract disorders in pregnancy, third trimester |
| O26.619 | Liver and biliary tract disorders in pregnancy, unspecified trimester |
| O26.62 | Liver and biliary tract disorders in childbirth |
| O26.63 | Liver and biliary tract disorders in the puerperium |
| O26.7 | Subluxation of symphysis (pubis) in pregnancy, childbirth and the puerperium |
| O26.71 | Subluxation of symphysis (pubis) in pregnancy |
| O26.711 | Subluxation of symphysis (pubis) in pregnancy, first trimester |
| O26.712 | Subluxation of symphysis (pubis) in pregnancy, second trimester |
| O26.713 | Subluxation of symphysis (pubis) in pregnancy, third trimester |
| O26.719 | Subluxation of symphysis (pubis) in pregnancy, unspecified trimester |
| O26.72 | Subluxation of symphysis (pubis) in childbirth |
| O26.73 | Subluxation of symphysis (pubis) in the puerperium |
| O26.8 | Other specified pregnancy related conditions |
| O26.81 | Pregnancy related exhaustion and fatigue |
| O26.811 | Pregnancy related exhaustion and fatigue, first trimester |
| O26.812 | Pregnancy related exhaustion and fatigue, second trimester |
| O26.813 | Pregnancy related exhaustion and fatigue, third trimester |
| O26.819 | Pregnancy related exhaustion and fatigue, unspecified trimester |
| O26.82 | Pregnancy related peripheral neuritis |
| O26.821 | Pregnancy related peripheral neuritis, first trimester |
| O26.822 | Pregnancy related peripheral neuritis, second trimester |
| O26.823 | Pregnancy related peripheral neuritis, third trimester |
| O26.829 | Pregnancy related peripheral neuritis, unspecified trimester |
| O26.83 | Pregnancy related renal disease |
| O26.831 | Pregnancy related renal disease, first trimester |
| O26.832 | Pregnancy related renal disease, second trimester |
| O26.833 | Pregnancy related renal disease, third trimester |
| O26.839 | Pregnancy related renal disease, unspecified trimester |
| O26.84 | Uterine size-date discrepancy complicating pregnancy |
| O26.841 | Uterine size-date discrepancy, first trimester |
| O26.842 | Uterine size-date discrepancy, second trimester |
| O26.843 | Uterine size-date discrepancy, third trimester |
| O26.849 | Uterine size-date discrepancy, unspecified trimester |
| O26.85 | Spotting complicating pregnancy |
| O26.851 | Spotting complicating pregnancy, first trimester |
| O26.852 | Spotting complicating pregnancy, second trimester |
| O26.853 | Spotting complicating pregnancy, third trimester |
| O26.859 | Spotting complicating pregnancy, unspecified trimester |
| O26.86 | Pruritic urticarial papules and plaques of pregnancy (PUPPP) |
| O26.87 | Cervical shortening |
| O26.872 | Cervical shortening, second trimester |
| O26.873 | Cervical shortening, third trimester |
| O26.879 | Cervical shortening, unspecified trimester |
| O26.89 | Other specified pregnancy related conditions |
| O26.891 | Other specified pregnancy related conditions, first trimester |
| O26.892 | Other specified pregnancy related conditions, second trimester |
| O26.893 | Other specified pregnancy related conditions, third trimester |
| O26.899 | Other specified pregnancy related conditions, unspecified trimester |
| O26.9 | Pregnancy related conditions, unspecified |
| O26.90 | Pregnancy related conditions, unspecified, unspecified trimester |
| O26.91 | Pregnancy related conditions, unspecified, first trimester |
| O26.92 | Pregnancy related conditions, unspecified, second trimester |
| O26.93 | Pregnancy related conditions, unspecified, third trimester |
| O28.0 | Abnormal hematological finding on antenatal screening of mother |
| O28.1 | Abnormal biochemical finding on antenatal screening of mother |
| O28.2 | Abnormal cytological finding on antenatal screening of mother |
| O28.3 | Abnormal ultrasonic finding on antenatal screening of mother |
| O28.4 | Abnormal radiological finding on antenatal screening of mother |
| O28.5 | Abnormal chromosomal and genetic finding on antenatal screening of mother |
| O28.8 | Other abnormal findings on antenatal screening of mother |
| O28.9 | Unspecified abnormal findings on antenatal screening of mother |
| O98.4 | Viral hepatitis complicating pregnancy, childbirth and the puerperium |
| O98.41 | Viral hepatitis complicating pregnancy |
| O98.411 | Viral hepatitis complicating pregnancy, first trimester |
| O98.412 | Viral hepatitis complicating pregnancy, second trimester |
| O98.413 | Viral hepatitis complicating pregnancy, third trimester |
| O98.419 | Viral hepatitis complicating pregnancy, unspecified trimester |
| O98.42 | Viral hepatitis complicating childbirth |
| O98.43 | Viral hepatitis complicating the puerperium |
| P35.3 | Congenital viral hepatitis |
| P58.0 | Neonatal jaundice due to bruising |
| P58.1 | Neonatal jaundice due to bleeding |
| P58.2 | Neonatal jaundice due to infection |
| P58.3 | Neonatal jaundice due to polycythemia |
| P58.4 | Neonatal jaundice due to drugs or toxins transmitted from mother or given to newborn |
| P58.41 | Neonatal jaundice due to drugs or toxins transmitted from mother |
| P58.42 | Neonatal jaundice due to drugs or toxins given to newborn |
| P58.5 | Neonatal jaundice due to swallowed maternal blood |
| P58.8 | Neonatal jaundice due to other specified excessive hemolysis |
| P58.9 | Neonatal jaundice due to excessive hemolysis, unspecified |
| P59.0 | Neonatal jaundice associated with preterm delivery |
| P59.1 | Inspissated bile syndrome |
| P59.2 | Neonatal jaundice from other and unspecified hepatocellular damage |
| P59.20 | Neonatal jaundice from unspecified hepatocellular damage |
| P59.29 | Neonatal jaundice from other hepatocellular damage |
| P59.3 | Neonatal jaundice from breast milk inhibitor |
| P59.8 | Neonatal jaundice from other specified causes |
| P59.9 | Neonatal jaundice, unspecified |
| R16.0 | Hepatomegaly, not elsewhere classified |
| R16.1 | Splenomegaly, not elsewhere classified |
| R16.2 | Hepatomegaly with splenomegaly, not elsewhere classified |
| R18.0 | Malignant ascites |
| R18.8 | Other ascites |
| R19.0 | Intra-abdominal and pelvic swelling, mass and lump |
| R19.00 | Intra-abdominal and pelvic swelling, mass and lump, unspecified site |
| R19.01 | Right upper quadrant abdominal swelling, mass and lump |
| R19.02 | Left upper quadrant abdominal swelling, mass and lump |
| R19.03 | Right lower quadrant abdominal swelling, mass and lump |
| R19.04 | Left lower quadrant abdominal swelling, mass and lump |
| R19.05 | Periumbilic swelling, mass or lump |
| R19.06 | Epigastric swelling, mass or lump |
| R19.07 | Generalized intra-abdominal and pelvic swelling, mass and lump |
| R19.09 | Other intra-abdominal and pelvic swelling, mass and lump |
| R19.1 | Abnormal bowel sounds |
| R19.11 | Absent bowel sounds |
| R19.12 | Hyperactive bowel sounds |
| R19.15 | Other abnormal bowel sounds |
| R19.2 | Visible peristalsis |
| R19.3 | Abdominal rigidity |
| R19.30 | Abdominal rigidity, unspecified site |
| R19.31 | Right upper quadrant abdominal rigidity |
| R19.32 | Left upper quadrant abdominal rigidity |
| R19.33 | Right lower quadrant abdominal rigidity |
| R19.34 | Left lower quadrant abdominal rigidity |
| R19.35 | Periumbilic abdominal rigidity |
| R19.36 | Epigastric abdominal rigidity |
| R19.37 | Generalized abdominal rigidity |
| R19.4 | Change in bowel habit |
| R19.5 | Other fecal abnormalities |
| R19.6 | Halitosis |
| R19.7 | Diarrhea, unspecified |
| R19.8 | Other specified symptoms and signs involving the digestive system and abdomen |
| R77.0 | Abnormality of albumin |
| R77.1 | Abnormality of globulin |
| R77.2 | Abnormality of alphafetoprotein |
| R77.8 | Other specified abnormalities of plasma proteins |
| R77.9 | Abnormality of plasma protein, unspecified |
| R78.0 | Finding of alcohol in blood |
| R78.1 | Finding of opiate drug in blood |
| R78.2 | Finding of cocaine in blood |
| R78.3 | Finding of hallucinogen in blood |
| R78.4 | Finding of other drugs of addictive potential in blood |
| R78.5 | Finding of other psychotropic drug in blood |
| R78.6 | Finding of steroid agent in blood |
| R78.7 | Finding of abnormal level of heavy metals in blood |
| R78.71 | Abnormal lead level in blood |
| R78.79 | Finding of abnormal level of heavy metals in blood |
| R78.8 | Finding of other specified substances, not normally found in blood |
| R78.81 | Bacteremia |
| R78.89 | Finding of other specified substances, not normally found in blood |
| R78.9 | Finding of unspecified substance, not normally found in blood |
| R80.0 | Isolated proteinuria |
| R80.1 | Persistent proteinuria, unspecified |
| R80.2 | Orthostatic proteinuria, unspecified |
| R80.3 | Bence Jones proteinuria |
| R80.8 | Other proteinuria |
| R80.9 | Proteinuria, unspecified |
| R94.0 | Abnormal results of function studies of central nervous system |
| R94.01 | Abnormal electroencephalogram [EEG] |
| R94.02 | Abnormal brain scan |
| R94.09 | Abnormal results of other function studies of central nervous system |
| R94.1 | Abnormal results of function studies of peripheral nervous system and special senses |
| R94.11 | Abnormal results of function studies of eye |
| R94.110 | Abnormal electro-oculogram [EOG] |
| R94.111 | Abnormal electroretinogram [ERG] |
| R94.112 | Abnormal visually evoked potential [VEP] |
| R94.113 | Abnormal oculomotor study |
| R94.118 | Abnormal results of other function studies of eye |
| R94.12 | Abnormal results of function studies of ear and other special senses |
| R94.120 | Abnormal auditory function study |
| R94.121 | Abnormal vestibular function study |
| R94.128 | Abnormal results of other function studies of ear and other special senses |
| R94.13 | Abnormal results of function studies of peripheral nervous system |
| R94.130 | Abnormal response to nerve stimulation, unspecified |
| R94.131 | Abnormal electromyogram [EMG] |
| R94.138 | Abnormal results of other function studies of peripheral nervous system |
| R94.2 | Abnormal results of pulmonary function studies |
| R94.3 | Abnormal results of cardiovascular function studies |
| R94.30 | Abnormal result of cardiovascular function study, unspecified |
| R94.31 | Abnormal electrocardiogram [ECG] [EKG] |
| R94.39 | Abnormal result of other cardiovascular function study |
| R94.4 | Abnormal results of kidney function studies |
| R94.5 | Abnormal results of liver function studies |
| R94.6 | Abnormal results of thyroid function studies |
| R94.7 | Abnormal results of other endocrine function studies |
| R94.8 | Abnormal results of function studies of other organs and systems |
| T39.0 | Poisoning by, adverse effect of and underdosing of salicylates |
| T39.01 | Poisoning by, adverse effect of and underdosing of aspirin |
| T39.011 | Poisoning by aspirin, accidental (unintentional) |
| T39.011A | Poisoning by aspirin, accidental (unintentional), initial encounter |
| T39.011D | Poisoning by aspirin, accidental (unintentional), subsequent encounter |
| T39.011S | Poisoning by aspirin, accidental (unintentional), sequela |
| T39.012 | Poisoning by aspirin, intentional self-harm |
| T39.012A | Poisoning by aspirin, intentional self-harm, initial encounter |
| T39.012D | Poisoning by aspirin, intentional self-harm, subsequent encounter |
| T39.012S | Poisoning by aspirin, intentional self-harm, sequela |
| T39.013 | Poisoning by aspirin, assault |
| T39.013A | Poisoning by aspirin, assault, initial encounter |
| T39.013D | Poisoning by aspirin, assault, subsequent encounter |
| T39.013S | Poisoning by aspirin, assault, sequela |
| T39.014 | Poisoning by aspirin, undetermined |
| T39.014A | Poisoning by aspirin, undetermined, initial encounter |
| T39.014D | Poisoning by aspirin, undetermined, subsequent encounter |
| T39.014S | Poisoning by aspirin, undetermined, sequela |
| T39.015 | Adverse effect of aspirin |
| T39.015A | Adverse effect of aspirin, initial encounter |
| T39.015D | Adverse effect of aspirin, subsequent encounter |
| T39.015S | Adverse effect of aspirin, sequela |
| T39.016 | Underdosing of aspirin |
| T39.016A | Underdosing of aspirin, initial encounter |
| T39.016D | Underdosing of aspirin, subsequent encounter |
| T39.016S | Underdosing of aspirin, sequela |
| T39.09 | Poisoning by, adverse effect of and underdosing of other salicylates |
| T39.091 | Poisoning by salicylates, accidental (unintentional) |
| T39.091A | Poisoning by salicylates, accidental (unintentional), initial encounter |
| T39.091D | Poisoning by salicylates, accidental (unintentional), subsequent encounter |
| T39.091S | Poisoning by salicylates, accidental (unintentional), sequela |
| T39.092 | Poisoning by salicylates, intentional self-harm |
| T39.092A | Poisoning by salicylates, intentional self-harm, initial encounter |
| T39.092D | Poisoning by salicylates, intentional self-harm, subsequent encounter |
| T39.092S | Poisoning by salicylates, intentional self-harm, sequela |
| T39.093 | Poisoning by salicylates, assault |
| T39.093A | Poisoning by salicylates, assault, initial encounter |
| T39.093D | Poisoning by salicylates, assault, subsequent encounter |
| T39.093S | Poisoning by salicylates, assault, sequela |
| T39.094 | Poisoning by salicylates, undetermined |
| T39.094A | Poisoning by salicylates, undetermined, initial encounter |
| T39.094D | Poisoning by salicylates, undetermined, subsequent encounter |
| T39.094S | Poisoning by salicylates, undetermined, sequela |
| T39.095 | Adverse effect of salicylates |
| T39.095A | Adverse effect of salicylates, initial encounter |
| T39.095D | Adverse effect of salicylates, subsequent encounter |
| T39.095S | Adverse effect of salicylates, sequela |
| T39.096 | Underdosing of salicylates |
| T39.096A | Underdosing of salicylates, initial encounter |
| T39.096D | Underdosing of salicylates, subsequent encounter |
| T39.096S | Underdosing of salicylates, sequela |
| T39.1 | Poisoning by, adverse effect of and underdosing of 4-Aminophenol derivatives |
| T39.1X | Poisoning by, adverse effect of and underdosing of 4-Aminophenol derivatives |
| T39.1X1 | Poisoning by 4-Aminophenol derivatives, accidental (unintentional) |
| T39.1X1A | Poisoning by 4-Aminophenol derivatives, accidental (unintentional), initial encounter |
| T39.1X1D | Poisoning by 4-Aminophenol derivatives, accidental (unintentional), subsequent encounter |
| T39.1X1S | Poisoning by 4-Aminophenol derivatives, accidental (unintentional), sequela |
| T39.1X2 | Poisoning by 4-Aminophenol derivatives, intentional self-harm |
| T39.1X2A | Poisoning by 4-Aminophenol derivatives, intentional self-harm, initial encounter |
| T39.1X2D | Poisoning by 4-Aminophenol derivatives, intentional self-harm, subsequent encounter |
| T39.1X2S | Poisoning by 4-Aminophenol derivatives, intentional self-harm, sequela |
| T39.1X3 | Poisoning by 4-Aminophenol derivatives, assault |
| T39.1X3A | Poisoning by 4-Aminophenol derivatives, assault, initial encounter |
| T39.1X3D | Poisoning by 4-Aminophenol derivatives, assault, subsequent encounter |
| T39.1X3S | Poisoning by 4-Aminophenol derivatives, assault, sequela |
| T39.1X4 | Poisoning by 4-Aminophenol derivatives, undetermined |
| T39.1X4A | Poisoning by 4-Aminophenol derivatives, undetermined, initial encounter |
| T39.1X4D | Poisoning by 4-Aminophenol derivatives, undetermined, subsequent encounter |
| T39.1X4S | Poisoning by 4-Aminophenol derivatives, undetermined, sequela |
| T39.1X5 | Adverse effect of 4-Aminophenol derivatives |
| T39.1X5A | Adverse effect of 4-Aminophenol derivatives, initial encounter |
| T39.1X5D | Adverse effect of 4-Aminophenol derivatives, subsequent encounter |
| T39.1X5S | Adverse effect of 4-Aminophenol derivatives, sequela |
| T39.1X6 | Underdosing of 4-Aminophenol derivatives |
| T39.1X6A | Underdosing of 4-Aminophenol derivatives, initial encounter |
| T39.1X6D | Underdosing of 4-Aminophenol derivatives, subsequent encounter |
| T39.1X6S | Underdosing of 4-Aminophenol derivatives, sequela |
| T39.2 | Poisoning by, adverse effect of and underdosing of pyrazolone derivatives |
| T39.2X | Poisoning by, adverse effect of and underdosing of pyrazolone derivatives |
| T39.2X1 | Poisoning by pyrazolone derivatives, accidental (unintentional) |
| T39.2X1A | Poisoning by pyrazolone derivatives, accidental (unintentional), initial encounter |
| T39.2X1D | Poisoning by pyrazolone derivatives, accidental (unintentional), subsequent encounter |
| T39.2X1S | Poisoning by pyrazolone derivatives, accidental (unintentional), sequela |
| T39.2X2 | Poisoning by pyrazolone derivatives, intentional self-harm |
| T39.2X2A | Poisoning by pyrazolone derivatives, intentional self-harm, initial encounter |
| T39.2X2D | Poisoning by pyrazolone derivatives, intentional self-harm, subsequent encounter |
| T39.2X2S | Poisoning by pyrazolone derivatives, intentional self-harm, sequela |
| T39.2X3 | Poisoning by pyrazolone derivatives, assault |
| T39.2X3A | Poisoning by pyrazolone derivatives, assault, initial encounter |
| T39.2X3D | Poisoning by pyrazolone derivatives, assault, subsequent encounter |
| T39.2X3S | Poisoning by pyrazolone derivatives, assault, sequela |
| T39.2X4 | Poisoning by pyrazolone derivatives, undetermined |
| T39.2X4A | Poisoning by pyrazolone derivatives, undetermined, initial encounter |
| T39.2X4D | Poisoning by pyrazolone derivatives, undetermined, subsequent encounter |
| T39.2X4S | Poisoning by pyrazolone derivatives, undetermined, sequela |
| T39.2X5 | Adverse effect of pyrazolone derivatives |
| T39.2X5A | Adverse effect of pyrazolone derivatives, initial encounter |
| T39.2X5D | Adverse effect of pyrazolone derivatives, subsequent encounter |
| T39.2X5S | Adverse effect of pyrazolone derivatives, sequela |
| T39.2X6 | Underdosing of pyrazolone derivatives |
| T39.2X6A | Underdosing of pyrazolone derivatives, initial encounter |
| T39.2X6D | Underdosing of pyrazolone derivatives, subsequent encounter |
| T39.2X6S | Underdosing of pyrazolone derivatives, sequela |
| T39.3 | Poisoning by, adverse effect of and underdosing of other nonsteroidal anti-inflammatory drugs [NSAID] |
| T39.31 | Poisoning by, adverse effect of and underdosing of propionic acid derivatives |
| T39.311 | Poisoning by propionic acid derivatives, accidental (unintentional) |
| T39.311A | Poisoning by propionic acid derivatives, accidental (unintentional), initial encounter |
| T39.311D | Poisoning by propionic acid derivatives, accidental (unintentional), subsequent encounter |
| T39.311S | Poisoning by propionic acid derivatives, accidental (unintentional), sequela |
| T39.312 | Poisoning by propionic acid derivatives, intentional self-harm |
| T39.312A | Poisoning by propionic acid derivatives, intentional self-harm, initial encounter |
| T39.312D | Poisoning by propionic acid derivatives, intentional self-harm, subsequent encounter |
| T39.312S | Poisoning by propionic acid derivatives, intentional self-harm, sequela |
| T39.313 | Poisoning by propionic acid derivatives, assault |
| T39.313A | Poisoning by propionic acid derivatives, assault, initial encounter |
| T39.313D | Poisoning by propionic acid derivatives, assault, subsequent encounter |
| T39.313S | Poisoning by propionic acid derivatives, assault, sequela |
| T39.314 | Poisoning by propionic acid derivatives, undetermined |
| T39.314A | Poisoning by propionic acid derivatives, undetermined, initial encounter |
| T39.314D | Poisoning by propionic acid derivatives, undetermined, subsequent encounter |
| T39.314S | Poisoning by propionic acid derivatives, undetermined, sequela |
| T39.315 | Adverse effect of propionic acid derivatives |
| T39.315A | Adverse effect of propionic acid derivatives, initial encounter |
| T39.315D | Adverse effect of propionic acid derivatives, subsequent encounter |
| T39.315S | Adverse effect of propionic acid derivatives, sequela |
| T39.316 | Underdosing of propionic acid derivatives |
| T39.316A | Underdosing of propionic acid derivatives, initial encounter |
| T39.316D | Underdosing of propionic acid derivatives, subsequent encounter |
| T39.316S | Underdosing of propionic acid derivatives, sequela |
| T39.39 | Poisoning by, adverse effect of and underdosing of other nonsteroidal anti-inflammatory drugs [NSAID] |
| T39.391 | Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], accidental (unintentional) |
| T39.391A | Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], accidental (unintentional), initial encounter |
| T39.391D | Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], accidental (unintentional), subsequent encounter |
| T39.391S | Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], accidental (unintentional), sequela |
| T39.392 | Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], intentional self-harm |
| T39.392A | Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], intentional self-harm, initial encounter |
| T39.392D | Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], intentional self-harm, subsequent encounter |
| T39.392S | Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], intentional self-harm, sequela |
| T39.393 | Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], assault |
| T39.393A | Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], assault, initial encounter |
| T39.393D | Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], assault, subsequent encounter |
| T39.393S | Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], assault, sequela |
| T39.394 | Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], undetermined |
| T39.394A | Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], undetermined, initial encounter |
| T39.394D | Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], undetermined, subsequent encounter |
| T39.394S | Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], undetermined, sequela |
| T39.395 | Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID] |
| T39.395A | Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter |
| T39.395D | Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], subsequent encounter |
| T39.395S | Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], sequela |
| T39.396 | Underdosing of other nonsteroidal anti-inflammatory drugs [NSAID] |
| T39.396A | Underdosing of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter |
| T39.396D | Underdosing of other nonsteroidal anti-inflammatory drugs [NSAID], subsequent encounter |
| T39.396S | Underdosing of other nonsteroidal anti-inflammatory drugs [NSAID], sequela |
| T39.4 | Poisoning by, adverse effect of and underdosing of antirheumatics, not elsewhere classified |
| T39.4X | Poisoning by, adverse effect of and underdosing of antirheumatics, not elsewhere classified |
| T39.4X1 | Poisoning by antirheumatics, not elsewhere classified, accidental (unintentional) |
| T39.4X1A | Poisoning by antirheumatics, not elsewhere classified, accidental (unintentional), initial encounter |
| T39.4X1D | Poisoning by antirheumatics, not elsewhere classified, accidental (unintentional), subsequent encounter |
| T39.4X1S | Poisoning by antirheumatics, not elsewhere classified, accidental (unintentional), sequela |
| T39.4X2 | Poisoning by antirheumatics, not elsewhere classified, intentional self-harm |
| T39.4X2A | Poisoning by antirheumatics, not elsewhere classified, intentional self-harm, initial encounter |
| T39.4X2D | Poisoning by antirheumatics, not elsewhere classified, intentional self-harm, subsequent encounter |
| T39.4X2S | Poisoning by antirheumatics, not elsewhere classified, intentional self-harm, sequela |
| T39.4X3 | Poisoning by antirheumatics, not elsewhere classified, assault |
| T39.4X3A | Poisoning by antirheumatics, not elsewhere classified, assault, initial encounter |
| T39.4X3D | Poisoning by antirheumatics, not elsewhere classified, assault, subsequent encounter |
| T39.4X3S | Poisoning by antirheumatics, not elsewhere classified, assault, sequela |
| T39.4X4 | Poisoning by antirheumatics, not elsewhere classified, undetermined |
| T39.4X4A | Poisoning by antirheumatics, not elsewhere classified, undetermined, initial encounter |
| T39.4X4D | Poisoning by antirheumatics, not elsewhere classified, undetermined, subsequent encounter |
| T39.4X4S | Poisoning by antirheumatics, not elsewhere classified, undetermined, sequela |
| T39.4X5 | Adverse effect of antirheumatics, not elsewhere classified |
| T39.4X5A | Adverse effect of antirheumatics, not elsewhere classified, initial encounter |
| T39.4X5D | Adverse effect of antirheumatics, not elsewhere classified, subsequent encounter |
| T39.4X5S | Adverse effect of antirheumatics, not elsewhere classified, sequela |
| T39.4X6 | Underdosing of antirheumatics, not elsewhere classified |
| T39.4X6A | Underdosing of antirheumatics, not elsewhere classified, initial encounter |
| T39.4X6D | Underdosing of antirheumatics, not elsewhere classified, subsequent encounter |
| T39.4X6S | Underdosing of antirheumatics, not elsewhere classified, sequela |
| T39.8 | Poisoning by, adverse effect of and underdosing of other nonopioid analgesics and antipyretics, not elsewhere classified |
| T39.8X | Poisoning by, adverse effect of and underdosing of other nonopioid analgesics and antipyretics, not elsewhere classified |
| T39.8X1 | Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, accidental (unintentional) |
| T39.8X1A | Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, accidental (unintentional), initial encounter |
| T39.8X1D | Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, accidental (unintentional), subsequent encounter |
| T39.8X1S | Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, accidental (unintentional), sequela |
| T39.8X2 | Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, intentional self-harm |
| T39.8X2A | Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, intentional self-harm, initial encounter |
| T39.8X2D | Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, intentional self-harm, subsequent encounter |
| T39.8X2S | Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, intentional self-harm, sequela |
| T39.8X3 | Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, assault |
| T39.8X3A | Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, assault, initial encounter |
| T39.8X3D | Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, assault, subsequent encounter |
| T39.8X3S | Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, assault, sequela |
| T39.8X4 | Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, undetermined |
| T39.8X4A | Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, undetermined, initial encounter |
| T39.8X4D | Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, undetermined, subsequent encounter |
| T39.8X4S | Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, undetermined, sequela |
| T39.8X5 | Adverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified |
| T39.8X5A | Adverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, initial encounter |
| T39.8X5D | Adverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, subsequent encounter |
| T39.8X5S | Adverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, sequela |
| T39.8X6 | Underdosing of other nonopioid analgesics and antipyretics, not elsewhere classified |
| T39.8X6A | Underdosing of other nonopioid analgesics and antipyretics, not elsewhere classified, initial encounter |
| T39.8X6D | Underdosing of other nonopioid analgesics and antipyretics, not elsewhere classified, subsequent encounter |
| T39.8X6S | Underdosing of other nonopioid analgesics and antipyretics, not elsewhere classified, sequela |
| T39.9 | Poisoning by, adverse effect of and underdosing of unspecified nonopioid analgesic, antipyretic and antirheumatic |
| T39.91 | Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, accidental (unintentional) |
| T39.91XA | Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, accidental (unintentional), initial encounter |
| T39.91XD | Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, accidental (unintentional), subsequent encounter |
| T39.91XS | Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, accidental (unintentional), sequela |
| T39.92 | Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, intentional self-harm |
| T39.92XA | Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, intentional self-harm, initial encounter |
| T39.92XD | Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, intentional self-harm, subsequent encounter |
| T39.92XS | Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, intentional self-harm, sequela |
| T39.93 | Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, assault |
| T39.93XA | Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, assault, initial encounter |
| T39.93XD | Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, assault, subsequent encounter |
| T39.93XS | Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, assault, sequela |
| T39.94 | Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, undetermined |
| T39.94XA | Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, undetermined, initial encounter |
| T39.94XD | Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, undetermined, subsequent encounter |
| T39.94XS | Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, undetermined, sequela |
| T39.95 | Adverse effect of unspecified nonopioid analgesic, antipyretic and antirheumatic |
| T39.95XA | Adverse effect of unspecified nonopioid analgesic, antipyretic and antirheumatic, initial encounter |
| T39.95XD | Adverse effect of unspecified nonopioid analgesic, antipyretic and antirheumatic, subsequent encounter |
| T39.95XS | Adverse effect of unspecified nonopioid analgesic, antipyretic and antirheumatic, sequela |
| T39.96 | Underdosing of unspecified nonopioid analgesic, antipyretic and antirheumatic |
| T39.96XA | Underdosing of unspecified nonopioid analgesic, antipyretic and antirheumatic, initial encounter |
| T39.96XD | Underdosing of unspecified nonopioid analgesic, antipyretic and antirheumatic, subsequent encounter |
| T39.96XS | Underdosing of unspecified nonopioid analgesic, antipyretic and antirheumatic, sequela |
| T40.0 | Poisoning by, adverse effect of and underdosing of opium |
| T40.0X | Poisoning by, adverse effect of and underdosing of opium |
| T40.0X1 | Poisoning by opium, accidental (unintentional) |
| T40.0X1A | Poisoning by opium, accidental (unintentional), initial encounter |
| T40.0X1D | Poisoning by opium, accidental (unintentional), subsequent encounter |
| T40.0X1S | Poisoning by opium, accidental (unintentional), sequela |
| T40.0X2 | Poisoning by opium, intentional self-harm |
| T40.0X2A | Poisoning by opium, intentional self-harm, initial encounter |
| T40.0X2D | Poisoning by opium, intentional self-harm, subsequent encounter |
| T40.0X2S | Poisoning by opium, intentional self-harm, sequela |
| T40.0X3 | Poisoning by opium, assault |
| T40.0X3A | Poisoning by opium, assault, initial encounter |
| T40.0X3D | Poisoning by opium, assault, subsequent encounter |
| T40.0X3S | Poisoning by opium, assault, sequela |
| T40.0X4 | Poisoning by opium, undetermined |
| T40.0X4A | Poisoning by opium, undetermined, initial encounter |
| T40.0X4D | Poisoning by opium, undetermined, subsequent encounter |
| T40.0X4S | Poisoning by opium, undetermined, sequela |
| T40.0X5 | Adverse effect of opium |
| T40.0X5A | Adverse effect of opium, initial encounter |
| T40.0X5D | Adverse effect of opium, subsequent encounter |
| T40.0X5S | Adverse effect of opium, sequela |
| T40.0X6 | Underdosing of opium |
| T40.0X6A | Underdosing of opium, initial encounter |
| T40.0X6D | Underdosing of opium, subsequent encounter |
| T40.0X6S | Underdosing of opium, sequela |
| T40.1 | Poisoning by and adverse effect of heroin |
| T40.1X | Poisoning by and adverse effect of heroin |
| T40.1X1 | Poisoning by heroin, accidental (unintentional) |
| T40.1X1A | Poisoning by heroin, accidental (unintentional), initial encounter |
| T40.1X1D | Poisoning by heroin, accidental (unintentional), subsequent encounter |
| T40.1X1S | Poisoning by heroin, accidental (unintentional), sequela |
| T40.1X2 | Poisoning by heroin, intentional self-harm |
| T40.1X2A | Poisoning by heroin, intentional self-harm, initial encounter |
| T40.1X2D | Poisoning by heroin, intentional self-harm, subsequent encounter |
| T40.1X2S | Poisoning by heroin, intentional self-harm, sequela |
| T40.1X3 | Poisoning by heroin, assault |
| T40.1X3A | Poisoning by heroin, assault, initial encounter |
| T40.1X3D | Poisoning by heroin, assault, subsequent encounter |
| T40.1X3S | Poisoning by heroin, assault, sequela |
| T40.1X4 | Poisoning by heroin, undetermined |
| T40.1X4A | Poisoning by heroin, undetermined, initial encounter |
| T40.1X4D | Poisoning by heroin, undetermined, subsequent encounter |
| T40.1X4S | Poisoning by heroin, undetermined, sequela |
| T40.2 | Poisoning by, adverse effect of and underdosing of other opioids |
| T40.2X | Poisoning by, adverse effect of and underdosing of other opioids |
| T40.2X1 | Poisoning by other opioids, accidental (unintentional) |
| T40.2X1A | Poisoning by other opioids, accidental (unintentional), initial encounter |
| T40.2X1D | Poisoning by other opioids, accidental (unintentional), subsequent encounter |
| T40.2X1S | Poisoning by other opioids, accidental (unintentional), sequela |
| T40.2X2 | Poisoning by other opioids, intentional self-harm |
| T40.2X2A | Poisoning by other opioids, intentional self-harm, initial encounter |
| T40.2X2D | Poisoning by other opioids, intentional self-harm, subsequent encounter |
| T40.2X2S | Poisoning by other opioids, intentional self-harm, sequela |
| T40.2X3 | Poisoning by other opioids, assault |
| T40.2X3A | Poisoning by other opioids, assault, initial encounter |
| T40.2X3D | Poisoning by other opioids, assault, subsequent encounter |
| T40.2X3S | Poisoning by other opioids, assault, sequela |
| T40.2X4 | Poisoning by other opioids, undetermined |
| T40.2X4A | Poisoning by other opioids, undetermined, initial encounter |
| T40.2X4D | Poisoning by other opioids, undetermined, subsequent encounter |
| T40.2X4S | Poisoning by other opioids, undetermined, sequela |
| T40.2X5 | Adverse effect of other opioids |
| T40.2X5A | Adverse effect of other opioids, initial encounter |
| T40.2X5D | Adverse effect of other opioids, subsequent encounter |
| T40.2X5S | Adverse effect of other opioids, sequela |
| T40.2X6 | Underdosing of other opioids |
| T40.2X6A | Underdosing of other opioids, initial encounter |
| T40.2X6D | Underdosing of other opioids, subsequent encounter |
| T40.2X6S | Underdosing of other opioids, sequela |
| T40.3 | Poisoning by, adverse effect of and underdosing of methadone |
| T40.3X | Poisoning by, adverse effect of and underdosing of methadone |
| T40.3X1 | Poisoning by methadone, accidental (unintentional) |
| T40.3X1A | Poisoning by methadone, accidental (unintentional), initial encounter |
| T40.3X1D | Poisoning by methadone, accidental (unintentional), subsequent encounter |
| T40.3X1S | Poisoning by methadone, accidental (unintentional), sequela |
| T40.3X2 | Poisoning by methadone, intentional self-harm |
| T40.3X2A | Poisoning by methadone, intentional self-harm, initial encounter |
| T40.3X2D | Poisoning by methadone, intentional self-harm, subsequent encounter |
| T40.3X2S | Poisoning by methadone, intentional self-harm, sequela |
| T40.3X3 | Poisoning by methadone, assault |
| T40.3X3A | Poisoning by methadone, assault, initial encounter |
| T40.3X3D | Poisoning by methadone, assault, subsequent encounter |
| T40.3X3S | Poisoning by methadone, assault, sequela |
| T40.3X4 | Poisoning by methadone, undetermined |
| T40.3X4A | Poisoning by methadone, undetermined, initial encounter |
| T40.3X4D | Poisoning by methadone, undetermined, subsequent encounter |
| T40.3X4S | Poisoning by methadone, undetermined, sequela |
| T40.3X5 | Adverse effect of methadone |
| T40.3X5A | Adverse effect of methadone, initial encounter |
| T40.3X5D | Adverse effect of methadone, subsequent encounter |
| T40.3X5S | Adverse effect of methadone, sequela |
| T40.3X6 | Underdosing of methadone |
| T40.3X6A | Underdosing of methadone, initial encounter |
| T40.3X6D | Underdosing of methadone, subsequent encounter |
| T40.3X6S | Underdosing of methadone, sequela |
| T40.4 | Poisoning by, adverse effect of and underdosing of other synthetic narcotics |
| T40.41 | Poisoning by, adverse effect of and underdosing of fentanyl or fentanyl analogs |
| T40.411 | Poisoning by fentanyl or fentanyl analogs, accidental (unintentional) |
| T40.411A | Poisoning by fentanyl or fentanyl analogs, accidental (unintentional), initial encounter |
| T40.411D | Poisoning by fentanyl or fentanyl analogs, accidental (unintentional), subsequent encounter |
| T40.411S | Poisoning by fentanyl or fentanyl analogs, accidental (unintentional), sequela |
| T40.412 | Poisoning by fentanyl or fentanyl analogs, intentional self-harm |
| T40.412A | Poisoning by fentanyl or fentanyl analogs, intentional self-harm, initial encounter |
| T40.412D | Poisoning by fentanyl or fentanyl analogs, intentional self-harm, subsequent encounter |
| T40.412S | Poisoning by fentanyl or fentanyl analogs, intentional self-harm, sequela |
| T40.413 | Poisoning by fentanyl or fentanyl analogs, assault |
| T40.413A | Poisoning by fentanyl or fentanyl analogs, assault, initial encounter |
| T40.413D | Poisoning by fentanyl or fentanyl analogs, assault, subsequent encounter |
| T40.413S | Poisoning by fentanyl or fentanyl analogs, assault, sequela |
| T40.414 | Poisoning by fentanyl or fentanyl analogs, undetermined |
| T40.414A | Poisoning by fentanyl or fentanyl analogs, undetermined, initial encounter |
| T40.414D | Poisoning by fentanyl or fentanyl analogs, undetermined, subsequent encounter |
| T40.414S | Poisoning by fentanyl or fentanyl analogs, undetermined, sequela |
| T40.415 | Adverse effect of fentanyl or fentanyl analogs |
| T40.415A | Adverse effect of fentanyl or fentanyl analogs, initial encounter |
| T40.415D | Adverse effect of fentanyl or fentanyl analogs, subsequent encounter |
| T40.415S | Adverse effect of fentanyl or fentanyl analogs, sequela |
| T40.416 | Underdosing of fentanyl or fentanyl analogs |
| T40.416A | Underdosing of fentanyl or fentanyl analogs, initial encounter |
| T40.416D | Underdosing of fentanyl or fentanyl analogs, subsequent encounter |
| T40.416S | Underdosing of fentanyl or fentanyl analogs, sequela |
| T40.42 | Poisoning by, adverse effect of and underdosing of tramadol |
| T40.421 | Poisoning by tramadol, accidental (unintentional) |
| T40.421A | Poisoning by tramadol, accidental (unintentional), initial encounter |
| T40.421D | Poisoning by tramadol, accidental (unintentional), subsequent encounter |
| T40.421S | Poisoning by tramadol, accidental (unintentional), sequela |
| T40.422 | Poisoning by tramadol, intentional self-harm |
| T40.422A | Poisoning by tramadol, intentional self-harm, initial encounter |
| T40.422D | Poisoning by tramadol, intentional self-harm, subsequent encounter |
| T40.422S | Poisoning by tramadol, intentional self-harm, sequela |
| T40.423 | Poisoning by tramadol, assault |
| T40.423A | Poisoning by tramadol, assault, initial encounter |
| T40.423D | Poisoning by tramadol, assault, subsequent encounter |
| T40.423S | Poisoning by tramadol, assault, sequela |
| T40.424 | Poisoning by tramadol, undetermined |
| T40.424A | Poisoning by tramadol, undetermined, initial encounter |
| T40.424D | Poisoning by tramadol, undetermined, subsequent encounter |
| T40.424S | Poisoning by tramadol, undetermined, sequela |
| T40.425 | Adverse effect of tramadol |
| T40.425A | Adverse effect of tramadol, initial encounter |
| T40.425D | Adverse effect of tramadol, subsequent encounter |
| T40.425S | Adverse effect of tramadol, sequela |
| T40.426 | Underdosing of tramadol |
| T40.426A | Underdosing of tramadol, initial encounter |
| T40.426D | Underdosing of tramadol, subsequent encounter |
| T40.426S | Underdosing of tramadol, sequela |
| T40.49 | Poisoning by, adverse effect of and underdosing of other synthetic narcotics |
| T40.491 | Poisoning by other synthetic narcotics, accidental (unintentional) |
| T40.491A | Poisoning by other synthetic narcotics, accidental (unintentional), initial encounter |
| T40.491D | Poisoning by other synthetic narcotics, accidental (unintentional), subsequent encounter |
| T40.491S | Poisoning by other synthetic narcotics, accidental (unintentional), sequela |
| T40.492 | Poisoning by other synthetic narcotics, intentional self-harm |
| T40.492A | Poisoning by other synthetic narcotics, intentional self-harm, initial encounter |
| T40.492D | Poisoning by other synthetic narcotics, intentional self-harm, subsequent encounter |
| T40.492S | Poisoning by other synthetic narcotics, intentional self-harm, sequela |
| T40.493 | Poisoning by other synthetic narcotics, assault |
| T40.493A | Poisoning by other synthetic narcotics, assault, initial encounter |
| T40.493D | Poisoning by other synthetic narcotics, assault, subsequent encounter |
| T40.493S | Poisoning by other synthetic narcotics, assault, sequela |
| T40.494 | Poisoning by other synthetic narcotics, undetermined |
| T40.494A | Poisoning by other synthetic narcotics, undetermined, initial encounter |
| T40.494D | Poisoning by other synthetic narcotics, undetermined, subsequent encounter |
| T40.494S | Poisoning by other synthetic narcotics, undetermined, sequela |
| T40.495 | Adverse effect of other synthetic narcotics |
| T40.495A | Adverse effect of other synthetic narcotics, initial encounter |
| T40.495D | Adverse effect of other synthetic narcotics, subsequent encounter |
| T40.495S | Adverse effect of other synthetic narcotics, sequela |
| T40.496 | Underdosing of other synthetic narcotics |
| T40.496A | Underdosing of other synthetic narcotics, initial encounter |
| T40.496D | Underdosing of other synthetic narcotics, subsequent encounter |
| T40.496S | Underdosing of other synthetic narcotics, sequela |
| T40.4X | |
| T40.4X1 | |
| T40.4X1A | |
| T40.4X1D | |
| T40.4X1S | |
| T40.4X2 | |
| T40.4X2A | |
| T40.4X2D | |
| T40.4X2S | |
| T40.4X3 | |
| T40.4X3A | |
| T40.4X3D | |
| T40.4X3S | |
| T40.4X4 | |
| T40.4X4A | |
| T40.4X4D | |
| T40.4X4S | |
| T40.4X5 | |
| T40.4X5A | |
| T40.4X5D | |
| T40.4X5S | |
| T40.4X6 | |
| T40.4X6A | |
| T40.4X6D | |
| T40.4X6S | |
| T40.5 | Poisoning by, adverse effect of and underdosing of cocaine |
| T40.5X | Poisoning by, adverse effect of and underdosing of cocaine |
| T40.5X1 | Poisoning by cocaine, accidental (unintentional) |
| T40.5X1A | Poisoning by cocaine, accidental (unintentional), initial encounter |
| T40.5X1D | Poisoning by cocaine, accidental (unintentional), subsequent encounter |
| T40.5X1S | Poisoning by cocaine, accidental (unintentional), sequela |
| T40.5X2 | Poisoning by cocaine, intentional self-harm |
| T40.5X2A | Poisoning by cocaine, intentional self-harm, initial encounter |
| T40.5X2D | Poisoning by cocaine, intentional self-harm, subsequent encounter |
| T40.5X2S | Poisoning by cocaine, intentional self-harm, sequela |
| T40.5X3 | Poisoning by cocaine, assault |
| T40.5X3A | Poisoning by cocaine, assault, initial encounter |
| T40.5X3D | Poisoning by cocaine, assault, subsequent encounter |
| T40.5X3S | Poisoning by cocaine, assault, sequela |
| T40.5X4 | Poisoning by cocaine, undetermined |
| T40.5X4A | Poisoning by cocaine, undetermined, initial encounter |
| T40.5X4D | Poisoning by cocaine, undetermined, subsequent encounter |
| T40.5X4S | Poisoning by cocaine, undetermined, sequela |
| T40.5X5 | Adverse effect of cocaine |
| T40.5X5A | Adverse effect of cocaine, initial encounter |
| T40.5X5D | Adverse effect of cocaine, subsequent encounter |
| T40.5X5S | Adverse effect of cocaine, sequela |
| T40.5X6 | Underdosing of cocaine |
| T40.5X6A | Underdosing of cocaine, initial encounter |
| T40.5X6D | Underdosing of cocaine, subsequent encounter |
| T40.5X6S | Underdosing of cocaine, sequela |
| T40.6 | Poisoning by, adverse effect of and underdosing of other and unspecified narcotics |
| T40.60 | Poisoning by, adverse effect of and underdosing of unspecified narcotics |
| T40.601 | Poisoning by unspecified narcotics, accidental (unintentional) |
| T40.601A | Poisoning by unspecified narcotics, accidental (unintentional), initial encounter |
| T40.601D | Poisoning by unspecified narcotics, accidental (unintentional), subsequent encounter |
| T40.601S | Poisoning by unspecified narcotics, accidental (unintentional), sequela |
| T40.602 | Poisoning by unspecified narcotics, intentional self-harm |
| T40.602A | Poisoning by unspecified narcotics, intentional self-harm, initial encounter |
| T40.602D | Poisoning by unspecified narcotics, intentional self-harm, subsequent encounter |
| T40.602S | Poisoning by unspecified narcotics, intentional self-harm, sequela |
| T40.603 | Poisoning by unspecified narcotics, assault |
| T40.603A | Poisoning by unspecified narcotics, assault, initial encounter |
| T40.603D | Poisoning by unspecified narcotics, assault, subsequent encounter |
| T40.603S | Poisoning by unspecified narcotics, assault, sequela |
| T40.604 | Poisoning by unspecified narcotics, undetermined |
| T40.604A | Poisoning by unspecified narcotics, undetermined, initial encounter |
| T40.604D | Poisoning by unspecified narcotics, undetermined, subsequent encounter |
| T40.604S | Poisoning by unspecified narcotics, undetermined, sequela |
| T40.605 | Adverse effect of unspecified narcotics |
| T40.605A | Adverse effect of unspecified narcotics, initial encounter |
| T40.605D | Adverse effect of unspecified narcotics, subsequent encounter |
| T40.605S | Adverse effect of unspecified narcotics, sequela |
| T40.606 | Underdosing of unspecified narcotics |
| T40.606A | Underdosing of unspecified narcotics, initial encounter |
| T40.606D | Underdosing of unspecified narcotics, subsequent encounter |
| T40.606S | Underdosing of unspecified narcotics, sequela |
| T40.69 | Poisoning by, adverse effect of and underdosing of other narcotics |
| T40.691 | Poisoning by other narcotics, accidental (unintentional) |
| T40.691A | Poisoning by other narcotics, accidental (unintentional), initial encounter |
| T40.691D | Poisoning by other narcotics, accidental (unintentional), subsequent encounter |
| T40.691S | Poisoning by other narcotics, accidental (unintentional), sequela |
| T40.692 | Poisoning by other narcotics, intentional self-harm |
| T40.692A | Poisoning by other narcotics, intentional self-harm, initial encounter |
| T40.692D | Poisoning by other narcotics, intentional self-harm, subsequent encounter |
| T40.692S | Poisoning by other narcotics, intentional self-harm, sequela |
| T40.693 | Poisoning by other narcotics, assault |
| T40.693A | Poisoning by other narcotics, assault, initial encounter |
| T40.693D | Poisoning by other narcotics, assault, subsequent encounter |
| T40.693S | Poisoning by other narcotics, assault, sequela |
| T40.694 | Poisoning by other narcotics, undetermined |
| T40.694A | Poisoning by other narcotics, undetermined, initial encounter |
| T40.694D | Poisoning by other narcotics, undetermined, subsequent encounter |
| T40.694S | Poisoning by other narcotics, undetermined, sequela |
| T40.695 | Adverse effect of other narcotics |
| T40.695A | Adverse effect of other narcotics, initial encounter |
| T40.695D | Adverse effect of other narcotics, subsequent encounter |
| T40.695S | Adverse effect of other narcotics, sequela |
| T40.696 | Underdosing of other narcotics |
| T40.696A | Underdosing of other narcotics, initial encounter |
| T40.696D | Underdosing of other narcotics, subsequent encounter |
| T40.696S | Underdosing of other narcotics, sequela |
| T40.7 | Poisoning by, adverse effect of and underdosing of cannabis (derivatives) |
| T40.7X | Poisoning by, adverse effect of and underdosing of cannabis (derivatives) |
| T40.7X1 | Poisoning by cannabis (derivatives), accidental (unintentional) |
| T40.7X1A | Poisoning by cannabis (derivatives), accidental (unintentional), initial encounter |
| T40.7X1D | Poisoning by cannabis (derivatives), accidental (unintentional), subsequent encounter |
| T40.7X1S | Poisoning by cannabis (derivatives), accidental (unintentional), sequela |
| T40.7X2 | Poisoning by cannabis (derivatives), intentional self-harm |
| T40.7X2A | Poisoning by cannabis (derivatives), intentional self-harm, initial encounter |
| T40.7X2D | Poisoning by cannabis (derivatives), intentional self-harm, subsequent encounter |
| T40.7X2S | Poisoning by cannabis (derivatives), intentional self-harm, sequela |
| T40.7X3 | Poisoning by cannabis (derivatives), assault |
| T40.7X3A | Poisoning by cannabis (derivatives), assault, initial encounter |
| T40.7X3D | Poisoning by cannabis (derivatives), assault, subsequent encounter |
| T40.7X3S | Poisoning by cannabis (derivatives), assault, sequela |
| T40.7X4 | Poisoning by cannabis (derivatives), undetermined |
| T40.7X4A | Poisoning by cannabis (derivatives), undetermined, initial encounter |
| T40.7X4D | Poisoning by cannabis (derivatives), undetermined, subsequent encounter |
| T40.7X4S | Poisoning by cannabis (derivatives), undetermined, sequela |
| T40.7X5 | Adverse effect of cannabis (derivatives) |
| T40.7X5A | Adverse effect of cannabis (derivatives), initial encounter |
| T40.7X5D | Adverse effect of cannabis (derivatives), subsequent encounter |
| T40.7X5S | Adverse effect of cannabis (derivatives), sequela |
| T40.7X6 | Underdosing of cannabis (derivatives) |
| T40.7X6A | Underdosing of cannabis (derivatives), initial encounter |
| T40.7X6D | Underdosing of cannabis (derivatives), subsequent encounter |
| T40.7X6S | Underdosing of cannabis (derivatives), sequela |
| T40.8 | Poisoning by and adverse effect of lysergide [LSD] |
| T40.8X | Poisoning by and adverse effect of lysergide [LSD] |
| T40.8X1 | Poisoning by lysergide [LSD], accidental (unintentional) |
| T40.8X1A | Poisoning by lysergide [LSD], accidental (unintentional), initial encounter |
| T40.8X1D | Poisoning by lysergide [LSD], accidental (unintentional), subsequent encounter |
| T40.8X1S | Poisoning by lysergide [LSD], accidental (unintentional), sequela |
| T40.8X2 | Poisoning by lysergide [LSD], intentional self-harm |
| T40.8X2A | Poisoning by lysergide [LSD], intentional self-harm, initial encounter |
| T40.8X2D | Poisoning by lysergide [LSD], intentional self-harm, subsequent encounter |
| T40.8X2S | Poisoning by lysergide [LSD], intentional self-harm, sequela |
| T40.8X3 | Poisoning by lysergide [LSD], assault |
| T40.8X3A | Poisoning by lysergide [LSD], assault, initial encounter |
| T40.8X3D | Poisoning by lysergide [LSD], assault, subsequent encounter |
| T40.8X3S | Poisoning by lysergide [LSD], assault, sequela |
| T40.8X4 | Poisoning by lysergide [LSD], undetermined |
| T40.8X4A | Poisoning by lysergide [LSD], undetermined, initial encounter |
| T40.8X4D | Poisoning by lysergide [LSD], undetermined, subsequent encounter |
| T40.8X4S | Poisoning by lysergide [LSD], undetermined, sequela |
| T40.9 | Poisoning by, adverse effect of and underdosing of other and unspecified psychodysleptics [hallucinogens] |
| T40.90 | Poisoning by, adverse effect of and underdosing of unspecified psychodysleptics [hallucinogens] |
| T40.901 | Poisoning by unspecified psychodysleptics [hallucinogens], accidental (unintentional) |
| T40.901A | Poisoning by unspecified psychodysleptics [hallucinogens], accidental (unintentional), initial encounter |
| T40.901D | Poisoning by unspecified psychodysleptics [hallucinogens], accidental (unintentional), subsequent encounter |
| T40.901S | Poisoning by unspecified psychodysleptics [hallucinogens], accidental (unintentional), sequela |
| T40.902 | Poisoning by unspecified psychodysleptics [hallucinogens], intentional self-harm |
| T40.902A | Poisoning by unspecified psychodysleptics [hallucinogens], intentional self-harm, initial encounter |
| T40.902D | Poisoning by unspecified psychodysleptics [hallucinogens], intentional self-harm, subsequent encounter |
| T40.902S | Poisoning by unspecified psychodysleptics [hallucinogens], intentional self-harm, sequela |
| T40.903 | Poisoning by unspecified psychodysleptics [hallucinogens], assault |
| T40.903A | Poisoning by unspecified psychodysleptics [hallucinogens], assault, initial encounter |
| T40.903D | Poisoning by unspecified psychodysleptics [hallucinogens], assault, subsequent encounter |
| T40.903S | Poisoning by unspecified psychodysleptics [hallucinogens], assault, sequela |
| T40.904 | Poisoning by unspecified psychodysleptics [hallucinogens], undetermined |
| T40.904A | Poisoning by unspecified psychodysleptics [hallucinogens], undetermined, initial encounter |
| T40.904D | Poisoning by unspecified psychodysleptics [hallucinogens], undetermined, subsequent encounter |
| T40.904S | Poisoning by unspecified psychodysleptics [hallucinogens], undetermined, sequela |
| T40.905 | Adverse effect of unspecified psychodysleptics [hallucinogens] |
| T40.905A | Adverse effect of unspecified psychodysleptics [hallucinogens], initial encounter |
| T40.905D | Adverse effect of unspecified psychodysleptics [hallucinogens], subsequent encounter |
| T40.905S | Adverse effect of unspecified psychodysleptics [hallucinogens], sequela |
| T40.906 | Underdosing of unspecified psychodysleptics [hallucinogens] |
| T40.906A | Underdosing of unspecified psychodysleptics [hallucinogens], initial encounter |
| T40.906D | Underdosing of unspecified psychodysleptics [hallucinogens], subsequent encounter |
| T40.906S | Underdosing of unspecified psychodysleptics [hallucinogens], sequela |
| T40.99 | Poisoning by, adverse effect of and underdosing of other psychodysleptics [hallucinogens] |
| T40.991 | Poisoning by other psychodysleptics [hallucinogens], accidental (unintentional) |
| T40.991A | Poisoning by other psychodysleptics [hallucinogens], accidental (unintentional), initial encounter |
| T40.991D | Poisoning by other psychodysleptics [hallucinogens], accidental (unintentional), subsequent encounter |
| T40.991S | Poisoning by other psychodysleptics [hallucinogens], accidental (unintentional), sequela |
| T40.992 | Poisoning by other psychodysleptics [hallucinogens], intentional self-harm |
| T40.992A | Poisoning by other psychodysleptics [hallucinogens], intentional self-harm, initial encounter |
| T40.992D | Poisoning by other psychodysleptics [hallucinogens], intentional self-harm, subsequent encounter |
| T40.992S | Poisoning by other psychodysleptics [hallucinogens], intentional self-harm, sequela |
| T40.993 | Poisoning by other psychodysleptics [hallucinogens], assault |
| T40.993A | Poisoning by other psychodysleptics [hallucinogens], assault, initial encounter |
| T40.993D | Poisoning by other psychodysleptics [hallucinogens], assault, subsequent encounter |
| T40.993S | Poisoning by other psychodysleptics [hallucinogens], assault, sequela |
| T40.994 | Poisoning by other psychodysleptics [hallucinogens], undetermined |
| T40.994A | Poisoning by other psychodysleptics [hallucinogens], undetermined, initial encounter |
| T40.994D | Poisoning by other psychodysleptics [hallucinogens], undetermined, subsequent encounter |
| T40.994S | Poisoning by other psychodysleptics [hallucinogens], undetermined, sequela |
| T40.995 | Adverse effect of other psychodysleptics [hallucinogens] |
| T40.995A | Adverse effect of other psychodysleptics [hallucinogens], initial encounter |
| T40.995D | Adverse effect of other psychodysleptics [hallucinogens], subsequent encounter |
| T40.995S | Adverse effect of other psychodysleptics [hallucinogens], sequela |
| T40.996 | Underdosing of other psychodysleptics [hallucinogens] |
| T40.996A | Underdosing of other psychodysleptics [hallucinogens], initial encounter |
| T40.996D | Underdosing of other psychodysleptics [hallucinogens], subsequent encounter |
| T40.996S | Underdosing of other psychodysleptics [hallucinogens], sequela |
| T86.0 | Complications of bone marrow transplant |
| T86.00 | Unspecified complication of bone marrow transplant |
| T86.01 | Bone marrow transplant rejection |
| T86.02 | Bone marrow transplant failure |
| T86.03 | Bone marrow transplant infection |
| T86.09 | Other complications of bone marrow transplant |
| T86.1 | Complications of kidney transplant |
| T86.10 | Unspecified complication of kidney transplant |
| T86.11 | Kidney transplant rejection |
| T86.12 | Kidney transplant failure |
| T86.13 | Kidney transplant infection |
| T86.19 | Other complication of kidney transplant |
| T86.2 | Complications of heart transplant |
| T86.20 | Unspecified complication of heart transplant |
| T86.21 | Heart transplant rejection |
| T86.22 | Heart transplant failure |
| T86.23 | Heart transplant infection |
| T86.29 | Other complications of heart transplant |
| T86.290 | Cardiac allograft vasculopathy |
| T86.298 | Other complications of heart transplant |
| T86.3 | Complications of heart-lung transplant |
| T86.30 | Unspecified complication of heart-lung transplant |
| T86.31 | Heart-lung transplant rejection |
| T86.32 | Heart-lung transplant failure |
| T86.33 | Heart-lung transplant infection |
| T86.39 | Other complications of heart-lung transplant |
| T86.4 | Complications of liver transplant |
| T86.40 | Unspecified complication of liver transplant |
| T86.41 | Liver transplant rejection |
| T86.42 | Liver transplant failure |
| T86.43 | Liver transplant infection |
| T86.49 | Other complications of liver transplant |
| T86.5 | Complications of stem cell transplant |
| T86.8 | Complications of other transplanted organs and tissues |
| T86.81 | Complications of lung transplant |
| T86.810 | Lung transplant rejection |
| T86.811 | Lung transplant failure |
| T86.812 | Lung transplant infection |
| T86.818 | Other complications of lung transplant |
| T86.819 | Unspecified complication of lung transplant |
| T86.82 | Complications of skin graft (allograft) (autograft) |
| T86.820 | Skin graft (allograft) rejection |
| T86.821 | Skin graft (allograft) (autograft) failure |
| T86.822 | Skin graft (allograft) (autograft) infection |
| T86.828 | Other complications of skin graft (allograft) (autograft) |
| T86.829 | Unspecified complication of skin graft (allograft) (autograft) |
| T86.83 | Complications of bone graft |
| T86.830 | Bone graft rejection |
| T86.831 | Bone graft failure |
| T86.832 | Bone graft infection |
| T86.838 | Other complications of bone graft |
| T86.839 | Unspecified complication of bone graft |
| T86.84 | Complications of corneal transplant |
| T86.840 | Corneal transplant rejection |
| T86.8401 | Corneal transplant rejection, right eye |
| T86.8402 | Corneal transplant rejection, left eye |
| T86.8403 | Corneal transplant rejection, bilateral |
| T86.8409 | Corneal transplant rejection, unspecified eye |
| T86.841 | Corneal transplant failure |
| T86.8411 | Corneal transplant failure, right eye |
| T86.8412 | Corneal transplant failure, left eye |
| T86.8413 | Corneal transplant failure, bilateral |
| T86.8419 | Corneal transplant failure, unspecified eye |
| T86.842 | Corneal transplant infection |
| T86.8421 | Corneal transplant infection, right eye |
| T86.8422 | Corneal transplant infection, left eye |
| T86.8423 | Corneal transplant infection, bilateral |
| T86.8429 | Corneal transplant infection, unspecified eye |
| T86.848 | Other complications of corneal transplant |
| T86.8481 | Other complications of corneal transplant, right eye |
| T86.8482 | Other complications of corneal transplant, left eye |
| T86.8483 | Other complications of corneal transplant, bilateral |
| T86.8489 | Other complications of corneal transplant, unspecified eye |
| T86.849 | Unspecified complication of corneal transplant |
| T86.8491 | Unspecified complication of corneal transplant, right eye |
| T86.8492 | Unspecified complication of corneal transplant, left eye |
| T86.8493 | Unspecified complication of corneal transplant, bilateral |
| T86.8499 | Unspecified complication of corneal transplant, unspecified eye |
| T86.85 | Complication of intestine transplant |
| T86.850 | Intestine transplant rejection |
| T86.851 | Intestine transplant failure |
| T86.852 | Intestine transplant infection |
| T86.858 | Other complications of intestine transplant |
| T86.859 | Unspecified complication of intestine transplant |
| T86.89 | Complications of other transplanted tissue |
| T86.890 | Other transplanted tissue rejection |
| T86.891 | Other transplanted tissue failure |
| T86.892 | Other transplanted tissue infection |
| T86.898 | Other complications of other transplanted tissue |
| T86.899 | Unspecified complication of other transplanted tissue |
| T86.9 | Complication of unspecified transplanted organ and tissue |
| T86.90 | Unspecified complication of unspecified transplanted organ and tissue |
| T86.91 | Unspecified transplanted organ and tissue rejection |
| T86.92 | Unspecified transplanted organ and tissue failure |
| T86.93 | Unspecified transplanted organ and tissue infection |
| T86.99 | Other complications of unspecified transplanted organ and tissue |
| Z00.0 | Encounter for general adult medical examination |
| Z00.00 | Encounter for general adult medical examination without abnormal findings |
| Z00.01 | Encounter for general adult medical examination with abnormal findings |
| Z00.1 | Encounter for newborn, infant and child health examinations |
| Z00.11 | Newborn health examination |
| Z00.110 | Health examination for newborn under 8 days old |
| Z00.111 | Health examination for newborn 8 to 28 days old |
| Z00.12 | Encounter for routine child health examination |
| Z00.121 | Encounter for routine child health examination with abnormal findings |
| Z00.129 | Encounter for routine child health examination without abnormal findings |
| Z00.2 | Encounter for examination for period of rapid growth in childhood |
| Z00.3 | Encounter for examination for adolescent development state |
| Z00.5 | Encounter for examination of potential donor of organ and tissue |
| Z00.6 | Encounter for examination for normal comparison and control in clinical research program |
| Z00.7 | Encounter for examination for period of delayed growth in childhood |
| Z00.70 | Encounter for examination for period of delayed growth in childhood without abnormal findings |
| Z00.71 | Encounter for examination for period of delayed growth in childhood with abnormal findings |
| Z00.8 | Encounter for other general examination |
| Z02.0 | Encounter for examination for admission to educational institution |
| Z02.1 | Encounter for pre-employment examination |
| Z02.2 | Encounter for examination for admission to residential institution |
| Z02.3 | Encounter for examination for recruitment to armed forces |
| Z02.4 | Encounter for examination for driving license |
| Z02.5 | Encounter for examination for participation in sport |
| Z02.6 | Encounter for examination for insurance purposes |
| Z02.7 | Encounter for issue of medical certificate |
| Z02.71 | Encounter for disability determination |
| Z02.79 | Encounter for issue of other medical certificate |
| Z02.8 | Encounter for other administrative examinations |
| Z02.81 | Encounter for paternity testing |
| Z02.82 | Encounter for adoption services |
| Z02.83 | Encounter for blood-alcohol and blood-drug test |
| Z02.89 | Encounter for other administrative examinations |
| Z02.9 | Encounter for administrative examinations, unspecified |
| Z04.1 | Encounter for examination and observation following transport accident |
| Z04.2 | Encounter for examination and observation following work accident |
| Z04.3 | Encounter for examination and observation following other accident |
| Z04.4 | Encounter for examination and observation following alleged rape |
| Z04.41 | Encounter for examination and observation following alleged adult rape |
| Z04.42 | Encounter for examination and observation following alleged child rape |
| Z04.6 | Encounter for general psychiatric examination, requested by authority |
| Z04.7 | Encounter for examination and observation following alleged physical abuse |
| Z04.71 | Encounter for examination and observation following alleged adult physical abuse |
| Z04.72 | Encounter for examination and observation following alleged child physical abuse |
| Z04.8 | Encounter for examination and observation for other specified reasons |
| Z04.81 | Encounter for examination and observation of victim following forced sexual exploitation |
| Z04.82 | Encounter for examination and observation of victim following forced labor exploitation |
| Z04.89 | Encounter for examination and observation for other specified reasons |
| Z04.9 | Encounter for examination and observation for unspecified reason |
| Z11.1 | Encounter for screening for respiratory tuberculosis |
| Z11.7 | Encounter for testing for latent tuberculosis infection |
| Z16.1 | Resistance to beta lactam antibiotics |
| Z16.10 | Resistance to unspecified beta lactam antibiotics |
| Z16.11 | Resistance to penicillins |
| Z16.12 | Extended spectrum beta lactamase (ESBL) resistance |
| Z16.19 | Resistance to other specified beta lactam antibiotics |
| Z16.2 | Resistance to other antibiotics |
| Z16.20 | Resistance to unspecified antibiotic |
| Z16.21 | Resistance to vancomycin |
| Z16.22 | Resistance to vancomycin related antibiotics |
| Z16.23 | Resistance to quinolones and fluoroquinolones |
| Z16.24 | Resistance to multiple antibiotics |
| Z16.29 | Resistance to other single specified antibiotic |
| Z16.3 | Resistance to other antimicrobial drugs |
| Z16.30 | Resistance to unspecified antimicrobial drugs |
| Z16.31 | Resistance to antiparasitic drug(s) |
| Z16.32 | Resistance to antifungal drug(s) |
| Z16.33 | Resistance to antiviral drug(s) |
| Z16.34 | Resistance to antimycobacterial drug(s) |
| Z16.341 | Resistance to single antimycobacterial drug |
| Z16.342 | Resistance to multiple antimycobacterial drugs |
| Z16.35 | Resistance to multiple antimicrobial drugs |
| Z16.39 | Resistance to other specified antimicrobial drug |
| Z20.0 | Contact with and (suspected) exposure to intestinal infectious diseases |
| Z20.01 | Contact with and (suspected) exposure to intestinal infectious diseases due to Escherichia coli (E. coli) |
| Z20.09 | Contact with and (suspected) exposure to other intestinal infectious diseases |
| Z20.1 | Contact with and (suspected) exposure to tuberculosis |
| Z20.2 | Contact with and (suspected) exposure to infections with a predominantly sexual mode of transmission |
| Z20.3 | Contact with and (suspected) exposure to rabies |
| Z20.4 | Contact with and (suspected) exposure to rubella |
| Z20.5 | Contact with and (suspected) exposure to viral hepatitis |
| Z20.6 | Contact with and (suspected) exposure to human immunodeficiency virus [HIV] |
| Z20.7 | Contact with and (suspected) exposure to pediculosis, acariasis and other infestations |
| Z20.8 | Contact with and (suspected) exposure to other communicable diseases |
| Z20.81 | Contact with and (suspected) exposure to other bacterial communicable diseases |
| Z20.810 | Contact with and (suspected) exposure to anthrax |
| Z20.811 | Contact with and (suspected) exposure to meningococcus |
| Z20.818 | Contact with and (suspected) exposure to other bacterial communicable diseases |
| Z20.82 | Contact with and (suspected) exposure to other viral communicable diseases |
| Z20.820 | Contact with and (suspected) exposure to varicella |
| Z20.821 | Contact with and (suspected) exposure to Zika virus |
| Z20.828 | Contact with and (suspected) exposure to other viral communicable diseases |
| Z20.89 | Contact with and (suspected) exposure to other communicable diseases |
| Z20.9 | Contact with and (suspected) exposure to unspecified communicable disease |
| Z22.5 | |
| Z22.50 | |
| Z22.51 | |
| Z22.52 | |
| Z22.59 | |
| Z22.7 | Latent tuberculosis |
| Z32.01 | Encounter for pregnancy test, result positive |
| Z33.1 | Pregnant state, incidental |
| Z33.2 | Encounter for elective termination of pregnancy |
| Z33.3 | Pregnant state, gestational carrier |
| Z34.0 | Encounter for supervision of normal first pregnancy |
| Z34.00 | Encounter for supervision of normal first pregnancy, unspecified trimester |
| Z34.01 | Encounter for supervision of normal first pregnancy, first trimester |
| Z34.02 | Encounter for supervision of normal first pregnancy, second trimester |
| Z34.03 | Encounter for supervision of normal first pregnancy, third trimester |
| Z34.8 | Encounter for supervision of other normal pregnancy |
| Z34.80 | Encounter for supervision of other normal pregnancy, unspecified trimester |
| Z34.81 | Encounter for supervision of other normal pregnancy, first trimester |
| Z34.82 | Encounter for supervision of other normal pregnancy, second trimester |
| Z34.83 | Encounter for supervision of other normal pregnancy, third trimester |
| Z34.9 | Encounter for supervision of normal pregnancy, unspecified |
| Z34.90 | Encounter for supervision of normal pregnancy, unspecified, unspecified trimester |
| Z34.91 | Encounter for supervision of normal pregnancy, unspecified, first trimester |
| Z34.92 | Encounter for supervision of normal pregnancy, unspecified, second trimester |
| Z34.93 | Encounter for supervision of normal pregnancy, unspecified, third trimester |
| Z36.0 | Encounter for antenatal screening for chromosomal anomalies |
| Z36.1 | Encounter for antenatal screening for raised alphafetoprotein level |
| Z36.2 | Encounter for other antenatal screening follow-up |
| Z36.3 | Encounter for antenatal screening for malformations |
| Z36.4 | Encounter for antenatal screening for fetal growth retardation |
| Z36.5 | Encounter for antenatal screening for isoimmunization |
| Z36.8 | Encounter for other antenatal screening |
| Z36.81 | Encounter for antenatal screening for hydrops fetalis |
| Z36.82 | Encounter for antenatal screening for nuchal translucency |
| Z36.83 | Encounter for fetal screening for congenital cardiac abnormalities |
| Z36.84 | Encounter for antenatal screening for fetal lung maturity |
| Z36.85 | Encounter for antenatal screening for Streptococcus B |
| Z36.86 | Encounter for antenatal screening for cervical length |
| Z36.87 | Encounter for antenatal screening for uncertain dates |
| Z36.88 | Encounter for antenatal screening for fetal macrosomia |
| Z36.89 | Encounter for other specified antenatal screening |
| Z36.8A | Encounter for antenatal screening for other genetic defects |
| Z36.9 | Encounter for antenatal screening, unspecified |
| Z67.1 | Type A blood |
| Z67.10 | Type A blood, Rh positive |
| Z67.11 | Type A blood, Rh negative |
| Z67.2 | Type B blood |
| Z67.20 | Type B blood, Rh positive |
| Z67.21 | Type B blood, Rh negative |
| Z67.3 | Type AB blood |
| Z67.30 | Type AB blood, Rh positive |
| Z67.31 | Type AB blood, Rh negative |
| Z67.4 | Type O blood |
| Z67.40 | Type O blood, Rh positive |
| Z67.41 | Type O blood, Rh negative |
| Z67.9 | Unspecified blood type |
| Z67.90 | Unspecified blood type, Rh positive |
| Z67.91 | Unspecified blood type, Rh negative |
| Z68.1 | Body mass index [BMI] 19.9 or less, adult |
| Z68.2 | Body mass index [BMI] 20-29, adult |
| Z68.20 | Body mass index [BMI] 20.0-20.9, adult |
| Z68.21 | Body mass index [BMI] 21.0-21.9, adult |
| Z68.22 | Body mass index [BMI] 22.0-22.9, adult |
| Z68.23 | Body mass index [BMI] 23.0-23.9, adult |
| Z68.24 | Body mass index [BMI] 24.0-24.9, adult |
| Z68.25 | Body mass index [BMI] 25.0-25.9, adult |
| Z68.26 | Body mass index [BMI] 26.0-26.9, adult |
| Z68.27 | Body mass index [BMI] 27.0-27.9, adult |
| Z68.28 | Body mass index [BMI] 28.0-28.9, adult |
| Z68.29 | Body mass index [BMI] 29.0-29.9, adult |
| Z68.3 | Body mass index [BMI] 30-39, adult |
| Z68.30 | Body mass index [BMI]30.0-30.9, adult |
| Z68.31 | Body mass index [BMI] 31.0-31.9, adult |
| Z68.32 | Body mass index [BMI] 32.0-32.9, adult |
| Z68.33 | Body mass index [BMI] 33.0-33.9, adult |
| Z68.34 | Body mass index [BMI] 34.0-34.9, adult |
| Z68.35 | Body mass index [BMI] 35.0-35.9, adult |
| Z68.36 | Body mass index [BMI] 36.0-36.9, adult |
| Z68.37 | Body mass index [BMI] 37.0-37.9, adult |
| Z68.38 | Body mass index [BMI] 38.0-38.9, adult |
| Z68.39 | Body mass index [BMI] 39.0-39.9, adult |
| Z68.4 | Body mass index [BMI] 40 or greater, adult |
| Z68.41 | Body mass index [BMI]40.0-44.9, adult |
| Z68.42 | Body mass index [BMI] 45.0-49.9, adult |
| Z68.43 | Body mass index [BMI] 50.0-59.9, adult |
| Z68.44 | Body mass index [BMI] 60.0-69.9, adult |
| Z68.45 | Body mass index [BMI] 70 or greater, adult |
| Z68.5 | Body mass index [BMI] pediatric |
| Z68.51 | Body mass index [BMI] pediatric, less than 5th percentile for age |
| Z68.52 | Body mass index [BMI] pediatric, 5th percentile to less than 85th percentile for age |
| Z68.53 | Body mass index [BMI] pediatric, 85th percentile to less than 95th percentile for age |
| Z68.54 | Body mass index [BMI] pediatric, greater than or equal to 95th percentile for age |
| Z77.0 | Contact with and (suspected) exposure to hazardous, chiefly nonmedicinal, chemicals |
| Z77.01 | Contact with and (suspected) exposure to hazardous metals |
| Z77.010 | Contact with and (suspected) exposure to arsenic |
| Z77.011 | Contact with and (suspected) exposure to lead |
| Z77.012 | Contact with and (suspected) exposure to uranium |
| Z77.018 | Contact with and (suspected) exposure to other hazardous metals |
| Z77.02 | Contact with and (suspected) exposure to hazardous aromatic compounds |
| Z77.020 | Contact with and (suspected) exposure to aromatic amines |
| Z77.021 | Contact with and (suspected) exposure to benzene |
| Z77.028 | Contact with and (suspected) exposure to other hazardous aromatic compounds |
| Z77.09 | Contact with and (suspected) exposure to other hazardous, chiefly nonmedicinal, chemicals |
| Z77.090 | Contact with and (suspected) exposure to asbestos |
| Z77.098 | Contact with and (suspected) exposure to other hazardous, chiefly nonmedicinal, chemicals |
| Z77.1 | Contact with and (suspected) exposure to environmental pollution and hazards in the physical environment |
| Z77.11 | Contact with and (suspected) exposure to environmental pollution |
| Z77.110 | Contact with and (suspected) exposure to air pollution |
| Z77.111 | Contact with and (suspected) exposure to water pollution |
| Z77.112 | Contact with and (suspected) exposure to soil pollution |
| Z77.118 | Contact with and (suspected) exposure to other environmental pollution |
| Z77.12 | Contact with and (suspected) exposure to hazards in the physical environment |
| Z77.120 | Contact with and (suspected) exposure to mold (toxic) |
| Z77.121 | Contact with and (suspected) exposure to harmful algae and algae toxins |
| Z77.122 | Contact with and (suspected) exposure to noise |
| Z77.123 | Contact with and (suspected) exposure to radon and other naturally occurring radiation |
| Z77.128 | Contact with and (suspected) exposure to other hazards in the physical environment |
| Z77.2 | Contact with and (suspected) exposure to other hazardous substances |
| Z77.21 | Contact with and (suspected) exposure to potentially hazardous body fluids |
| Z77.22 | Contact with and (suspected) exposure to environmental tobacco smoke (acute) (chronic) |
| Z77.29 | Contact with and (suspected) exposure to other hazardous substances |
| Z77.9 | Other contact with and (suspected) exposures hazardous to health |
| Z79.1 | Long term (current) use of non-steroidal anti-inflammatories (NSAID) |
| Z79.5 | Long term (current) use of steroids |
| Z79.8 | Other long term (current) drug therapy |
| Z79.89 | Other long term (current) drug therapy |
| Z79.890 | Hormone replacement therapy |
| Z79.891 | Long term (current) use of opiate analgesic |
| Z79.899 | Other long term (current) drug therapy |
| Z84.0 | Family history of diseases of the skin and subcutaneous tissue |
| Z84.1 | Family history of disorders of kidney and ureter |
| Z84.2 | Family history of other diseases of the genitourinary system |
| Z84.3 | Family history of consanguinity |
| Z84.8 | Family history of other specified conditions |
| Z84.81 | Family history of carrier of genetic disease |
| Z84.82 | Family history of sudden infant death syndrome |
| Z84.89 | Family history of other specified conditions |
| Z85.0 | Personal history of malignant neoplasm of digestive organs |
| Z85.00 | Personal history of malignant neoplasm of unspecified digestive organ |
| Z85.01 | Personal history of malignant neoplasm of esophagus |
| Z85.02 | Personal history of malignant neoplasm of stomach |
| Z85.020 | Personal history of malignant carcinoid tumor of stomach |
| Z85.028 | Personal history of other malignant neoplasm of stomach |
| Z85.03 | Personal history of malignant neoplasm of large intestine |
| Z85.030 | Personal history of malignant carcinoid tumor of large intestine |
| Z85.038 | Personal history of other malignant neoplasm of large intestine |
| Z85.04 | Personal history of malignant neoplasm of rectum, rectosigmoid junction, and anus |
| Z85.040 | Personal history of malignant carcinoid tumor of rectum |
| Z85.048 | Personal history of other malignant neoplasm of rectum, rectosigmoid junction, and anus |
| Z85.05 | Personal history of malignant neoplasm of liver |
| Z85.06 | Personal history of malignant neoplasm of small intestine |
| Z85.060 | Personal history of malignant carcinoid tumor of small intestine |
| Z85.068 | Personal history of other malignant neoplasm of small intestine |
| Z85.07 | Personal history of malignant neoplasm of pancreas |
| Z85.09 | Personal history of malignant neoplasm of other digestive organs |
| Z85.1 | Personal history of malignant neoplasm of trachea, bronchus and lung |
| Z85.11 | Personal history of malignant neoplasm of bronchus and lung |
| Z85.110 | Personal history of malignant carcinoid tumor of bronchus and lung |
| Z85.118 | Personal history of other malignant neoplasm of bronchus and lung |
| Z85.12 | Personal history of malignant neoplasm of trachea |
| Z85.2 | Personal history of malignant neoplasm of other respiratory and intrathoracic organs |
| Z85.20 | Personal history of malignant neoplasm of unspecified respiratory organ |
| Z85.21 | Personal history of malignant neoplasm of larynx |
| Z85.22 | Personal history of malignant neoplasm of nasal cavities, middle ear, and accessory sinuses |
| Z85.23 | Personal history of malignant neoplasm of thymus |
| Z85.230 | Personal history of malignant carcinoid tumor of thymus |
| Z85.238 | Personal history of other malignant neoplasm of thymus |
| Z85.29 | Personal history of malignant neoplasm of other respiratory and intrathoracic organs |
| Z85.3 | Personal history of malignant neoplasm of breast |
| Z85.4 | Personal history of malignant neoplasm of genital organs |
| Z85.40 | Personal history of malignant neoplasm of unspecified female genital organ |
| Z85.41 | Personal history of malignant neoplasm of cervix uteri |
| Z85.42 | Personal history of malignant neoplasm of other parts of uterus |
| Z85.43 | Personal history of malignant neoplasm of ovary |
| Z85.44 | Personal history of malignant neoplasm of other female genital organs |
| Z85.45 | Personal history of malignant neoplasm of unspecified male genital organ |
| Z85.46 | Personal history of malignant neoplasm of prostate |
| Z85.47 | Personal history of malignant neoplasm of testis |
| Z85.48 | Personal history of malignant neoplasm of epididymis |
| Z85.49 | Personal history of malignant neoplasm of other male genital organs |
| Z85.5 | Personal history of malignant neoplasm of urinary tract |
| Z85.50 | Personal history of malignant neoplasm of unspecified urinary tract organ |
| Z85.51 | Personal history of malignant neoplasm of bladder |
| Z85.52 | Personal history of malignant neoplasm of kidney |
| Z85.520 | Personal history of malignant carcinoid tumor of kidney |
| Z85.528 | Personal history of other malignant neoplasm of kidney |
| Z85.53 | Personal history of malignant neoplasm of renal pelvis |
| Z85.54 | Personal history of malignant neoplasm of ureter |
| Z85.59 | Personal history of malignant neoplasm of other urinary tract organ |
| Z85.6 | Personal history of leukemia |
| Z85.7 | Personal history of other malignant neoplasms of lymphoid, hematopoietic and related tissues |
| Z85.71 | Personal history of Hodgkin lymphoma |
| Z85.72 | Personal history of non-Hodgkin lymphomas |
| Z85.79 | Personal history of other malignant neoplasms of lymphoid, hematopoietic and related tissues |
| Z85.8 | Personal history of malignant neoplasms of other organs and systems |
| Z85.81 | Personal history of malignant neoplasm of lip, oral cavity, and pharynx |
| Z85.810 | Personal history of malignant neoplasm of tongue |
| Z85.818 | Personal history of malignant neoplasm of other sites of lip, oral cavity, and pharynx |
| Z85.819 | Personal history of malignant neoplasm of unspecified site of lip, oral cavity, and pharynx |
| Z85.82 | Personal history of malignant neoplasm of skin |
| Z85.820 | Personal history of malignant melanoma of skin |
| Z85.821 | Personal history of Merkel cell carcinoma |
| Z85.828 | Personal history of other malignant neoplasm of skin |
| Z85.83 | Personal history of malignant neoplasm of bone and soft tissue |
| Z85.830 | Personal history of malignant neoplasm of bone |
| Z85.831 | Personal history of malignant neoplasm of soft tissue |
| Z85.84 | Personal history of malignant neoplasm of eye and nervous tissue |
| Z85.840 | Personal history of malignant neoplasm of eye |
| Z85.841 | Personal history of malignant neoplasm of brain |
| Z85.848 | Personal history of malignant neoplasm of other parts of nervous tissue |
| Z85.85 | Personal history of malignant neoplasm of endocrine glands |
| Z85.850 | Personal history of malignant neoplasm of thyroid |
| Z85.858 | Personal history of malignant neoplasm of other endocrine glands |
| Z85.89 | Personal history of malignant neoplasm of other organs and systems |
| Z85.9 | Personal history of malignant neoplasm, unspecified |
| Z86.11 | Personal history of tuberculosis |
| Z86.15 | Personal history of latent tuberculosis infection |